CCAAT/enhancer	B-protein
binding	I-protein
protein	I-protein
epsilon	I-protein
is	O
preferentially	O
up-regulated	O
during	O
granulocytic	O
differentiation	O
and	O
its	O
functional	O
versatility	O
is	O
determined	O
by	O
alternative	O
use	O
of	O
promoters	B-DNA
and	O
differential	O
splicing	O
.	O

CCAAT/enhancer	B-protein
binding	I-protein
protein	I-protein
(	I-protein
C/EBP	I-protein
)	I-protein
epsilon	I-protein
is	O
a	O
recently	O
cloned	O
member	O
of	O
the	O
C/EBP	B-protein
family	I-protein
of	O
transcription	B-protein
factors	I-protein
and	O
is	O
expressed	O
exclusively	O
in	O
cells	O
of	O
hematopoietic	O
origin	O
.	O

The	O
human	B-DNA
C/EBPepsilon	I-DNA
gene	I-DNA
is	O
transcribed	O
by	O
two	O
alternative	O
promoters	B-DNA
,	O
Palpha	B-DNA
and	O
Pbeta	B-DNA
.	O

A	O
combination	O
of	O
differential	O
splicing	O
and	O
alternative	O
use	O
of	O
promoters	B-DNA
generates	O
four	O
mRNA	B-RNA
isoforms	I-RNA
,	O
of	O
2.6	O
kb	O
and	O
1.3-1.5	O
kb	O
in	O
size	O
.	O

These	O
transcripts	O
can	O
encode	O
three	O
proteins	O
of	O
calculated	O
molecular	O
mass	O
32.2	B-RNA
kDa	I-RNA
,	O
27.8	B-RNA
kDa	I-RNA
,	O
and	O
14.3	B-RNA
kDa	I-RNA
.	O

Accordingly	O
,	O
Western	O
blots	O
with	O
antibodies	B-protein
specific	O
for	O
the	O
DNA-binding	O
domain	O
,	O
that	O
is	O
common	O
to	O
all	O
forms	O
,	O
identify	O
multiple	O
proteins	O
.	O

C/EBPepsilon	B-RNA
mRNA	I-RNA
was	O
greatly	O
induced	O
during	O
in	O
vitro	O
granulocytic	O
differentiation	O
of	O
human	B-cell_type
primary	I-cell_type
CD34	I-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
cells	I-cell_type
.	O

Retinoic	O
acid	O
treatment	O
of	O
HL60	B-cell_line
promyelocytic	I-cell_line
leukemia	I-cell_line
cells	I-cell_line
for	O
24	O
hr	O
induced	O
C/EBPepsilon	B-RNA
mRNA	I-RNA
levels	O
by	O
4-fold	O
,	O
while	O
prolonged	O
treatment	O
gradually	O
reduced	O
mRNA	O
expression	O
to	O
pretreatment	O
levels	O
.	O

Transient	O
transfection	O
experiments	O
with	O
expression	O
vectors	O
for	O
two	O
of	O
the	O
isoforms	O
demonstrated	O
that	O
the	O
32.2-kDa	B-protein
protein	I-protein
is	O
an	O
activator	O
of	O
transcription	O
of	O
granulocyte	B-DNA
colony-stimulating	I-DNA
factor	I-DNA
receptor	I-DNA
promoter	I-DNA
,	O
while	O
the	O
14.3-kDa	B-protein
protein	I-protein
is	O
not	O
.	O

Thus	O
,	O
C/EBPepsilon	B-protein
is	O
regulated	O
in	O
a	O
complex	O
fashion	O
and	O
may	O
play	O
a	O
role	O
in	O
the	O
regulation	O
of	O
genes	O
involved	O
in	O
myeloid	O
differentiation	O
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

94	NULL
,	NULL
pp	NULL
.	NULL

6462-6467	NULL
,	NULL
June	NULL
1997	NULL
Medical	NULL
Sciences	NULL
CCAAT/enhancer	NULL
binding	NULL
protein	NULL
&	NULL
is	NULL
preferentially	NULL
up-regulated	NULL
during	NULL
granulocytic	NULL
differentiation	NULL
and	NULL
its	NULL
functional	NULL
versatility	NULL
is	NULL
determined	NULL
by	NULL
alternative	NULL
use	NULL
of	NULL
promoters	NULL
and	NULL
differential	NULL
splicing	NULL
YaAMANAKA*	NULL
,	NULL
GuN-Do	NULL
Kim*	NULL
,	NULL
HANNA	NULL
S.	NULL
RabpomskaAt	NULL
,	NULL
JULIE	NULL
LekstROoM-HimEs*	NULL
,	NULL
Laura	NULL
T.	NULL
SmitH	NULL
?	NULL

t	NULL
,	NULL
PER	NULL
ANTONSONT	NULL
,	NULL
DANIEL	NULL
G.	NULL
TENENT	NULL
,	NULL
AnD	NULL
K.EANTHIS	NULL
G.	NULL
XantHOoProuLos*§	NULL
*Clinical	NULL
Gene	NULL
Therapy	NULL
Branch	NULL
,	NULL
National	NULL
Human	NULL
Genome	NULL
Research	NULL
Institute	NULL
,	NULL
Building	NULL
10	NULL
,	NULL
Room	NULL
10C103	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892-1851	NULL
;	NULL
THematology/Oncology	NULL
Division	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Beth	NULL
Israel	NULL
Hospital	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02215	NULL
;	NULL
and	NULL
*Institute	NULL
of	NULL
Cancer	NULL
Research	NULL
,	NULL
Royal	NULL
Cancer	NULL
Hospital	NULL
,	NULL
The	NULL
Haddow	NULL
Laboratories	NULL
,	NULL
15	NULL
Cotswold	NULL
Road	NULL
,	NULL
Belmont	NULL
,	NULL
Sutton	NULL
,	NULL
Surrey	NULL
SM2	NULL
5NG	NULL
,	NULL
United	NULL
Kingdom	NULL
Communicated	NULL
by	NULL
Francis	NULL
S.	NULL
Collins	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
,	NULL
April	NULL
16	NULL
,	NULL
1997	NULL
(	NULL
received	NULL
for	NULL
review	NULL
January	NULL
27	NULL
,	NULL
1997	NULL
)	NULL
ABSTRACT	NULL
CCAAT	NULL
/enhancer	NULL
binding	NULL
protein	NULL
(	NULL
C/EBP	NULL
)	NULL
£	NULL
is	NULL
a	NULL
recently	NULL
cloned	NULL
member	NULL
of	NULL
the	NULL
C/EBP	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
and	NULL
is	NULL
expressed	NULL
exclusively	NULL
in	NULL
cells	NULL
of	NULL
hematopoietic	NULL
origin	NULL
.	NULL

The	NULL
human	NULL
C/EBP	NULL
&	NULL
gene	NULL
is	NULL
transcribed	NULL
by	NULL
two	NULL
alternative	NULL
promoters	NULL
,	NULL
Pa	NULL
and	NULL
PB	NULL
.	NULL

A	NULL
combination	NULL
of	NULL
differential	NULL
splicing	NULL
and	NULL
alternative	NULL
use	NULL
of	NULL
promoters	NULL
generates	NULL
four	NULL
mRNA	NULL
isoforms	NULL
,	NULL
of	NULL
2.6	NULL
kb	NULL
and	NULL
1.3-1.5	NULL
kb	NULL
in	NULL
size	NULL
.	NULL

These	NULL
transcripts	NULL
can	NULL
encode	NULL
three	NULL
proteins	NULL
of	NULL
calculated	NULL
molecular	NULL
mass	NULL
32.2	NULL
kDa	NULL
,	NULL
27.8	NULL
kDa	NULL
,	NULL
and	NULL
14.3	NULL
kDa	NULL
.	NULL

Accord-ingly	NULL
,	NULL
Western	NULL
blots	NULL
with	NULL
antibodies	NULL
specific	NULL
for	NULL
the	NULL
DNA-binding	NULL
domain	NULL
,	NULL
that	NULL
is	NULL
common	NULL
to	NULL
all	NULL
forms	NULL
,	NULL
identify	NULL
multiple	NULL
proteins	NULL
.	NULL

mRNA	NULL
was	NULL
greatly	NULL
induced	NULL
during	NULL
in	NULL
vitro	NULL
granulocytic	NULL
differentiation	NULL
of	NULL
human	NULL
primary	NULL
CD34*	NULL
cells	NULL
.	NULL

Retinoic	NULL
acid	NULL
treatment	NULL
of	NULL
HL60	NULL
promyelocytic	NULL
leukemia	NULL
cells	NULL
for	NULL
24	NULL
hr	NULL
induced	NULL
C/EBP	NULL
:	NULL
mRNA	NULL
levels	NULL
by	NULL
4-fold	NULL
,	NULL
while	NULL
prolonged	NULL
treatment	NULL
gradually	NULL
reduced	NULL
mRNA	NULL
expression	NULL
to	NULL
pretreatment	NULL
levels	NULL
.	NULL

Transient	NULL
transfection	NULL
experiments	NULL
with	NULL
expression	NULL
vectors	NULL
for	NULL
two	NULL
of	NULL
the	NULL
isoforms	NULL
demonstrated	NULL
that	NULL
the	NULL
32.2-kDa	NULL
protein	NULL
is	NULL
an	NULL
activator	NULL
of	NULL
transcription	NULL
of	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
receptor	NULL
promoter	NULL
,	NULL
while	NULL
the	NULL
14.3-kDa	NULL
protein	NULL
is	NULL
not	NULL
.	NULL

Thus	NULL
,	NULL
C/EBP	NULL
:	NULL
is	NULL
regulated	NULL
in	NULL
a	NULL
complex	NULL
fashion	NULL
and	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
myeloid	NULL
differentiation	NULL
.	NULL

Hematopoietic	NULL
stem	NULL
cells	NULL
have	NULL
the	NULL
ability	NULL
to	NULL
promote	NULL
continuous	NULL
self-renewal	NULL
by	NULL
controlled	NULL
proliferation	NULL
and	NULL
expansive	NULL
differentiation	NULL
into	NULL
all	NULL
cells	NULL
of	NULL
hematopoietic	NULL
lineages	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
molecular	NULL
mechanisms	NULL
that	NULL
direct	NULL
cellular	NULL
proliferation	NULL
and	NULL
differentiation	NULL
during	NULL
hematopoiesis	NULL
depends	NULL
,	NULL
partly	NULL
,	NULL
on	NULL
the	NULL
action	NULL
of	NULL
certain	NULL
transcription	NULL
factors	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

Several	NULL
members	NULL
of	NULL
the	NULL
basic	NULL
region-leucine	NULL
zipper	NULL
(	NULL
bZIP	NULL
)	NULL
class	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
the	NULL
CCAAT	NULL
binding	NULL
protein	NULL
(	NULL
C/EBP	NULL
)	NULL
family	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
differentiation	NULL
of	NULL
hematopoietic	NULL
cells	NULL
(	NULL
1-5	NULL
)	NULL
.	NULL

C/EBP	NULL
proteins	NULL
have	NULL
highly	NULL
conserved	NULL
bZIP	NULL
C-terminal	NULL
regions	NULL
,	NULL
but	NULL
differ	NULL
in	NULL
their	NULL
N-terminal	NULL
regions	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

A	NULL
consensus	NULL
site	NULL
,	NULL
5'-A	NULL
,	NULL
qT	NULL
;	NULL
1T	NULL
;	NULL
G1C	NULL
,	NULL
GoC1AzAsT4-3	NULL
'	NULL
,	NULL
has	NULL
been	NULL
identified	NULL
as	NULL
the	NULL
target	NULL
for	NULL
interactions	NULL
between	NULL
DNA	NULL
and	NULL
the	NULL
C/EBP	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
such	NULL
sites	NULL
either	NULL
as	NULL
homodimers	NULL
or	NULL
heterodimers	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Dimerization	NULL
is	NULL
a	NULL
prerequisite	NULL
for	NULL
the	NULL
ability	NULL
of	NULL
these	NULL
proteins	NULL
to	NULL
bind	NULL
DNA	NULL
.	NULL

To	NULL
date	NULL
,	NULL
six	NULL
mammalian	NULL
members	NULL
have	NULL
been	NULL
characterized	NULL
,	NULL
C/EBPa	NULL
,	NULL
C/EBPB	NULL
,	NULL
C/EBPy	NULL
,	NULL
C/EBP3	NULL
,	NULL
C/EBPs	NULL
,	NULL
and	NULL
C/EBPZ	NULL
(	NULL
5	NULL
,	NULL
6	NULL
,	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

C/EBPa	NULL
,	NULL
C/EBPB	NULL
,	NULL
and	NULL
C/EBP8	NULL
are	NULL
activators	NULL
of	NULL
transcription	NULL
and	NULL
are	NULL
able	NULL
to	NULL
transactivate	NULL
a	NULL
variety	NULL
of	NULL
target	NULL
genes	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
C/EBPy	NULL
and	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1997	NULL
by	NULL
The	NULL
National	NULL
Academy	NULL
of	NULL
Sciences	NULL
0027-8424	NULL
/97/946462-6	NULL
$	NULL
2.00/0	NULL
6462	NULL
lack	NULL
transactivation	NULL
domains	NULL
and	NULL
instead	NULL
act	NULL
as	NULL
transdominant	NULL
repressors	NULL
of	NULL
transcription	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
.	NULL

The	NULL
high	NULL
degree	NULL
of	NULL
similarity	NULL
of	NULL
the	NULL
DNA-binding	NULL
and	NULL
dimerization	NULL
domains	NULL
of	NULL
the	NULL
C/EBP	NULL
proteins	NULL
allows	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
C/EBP	NULL
homodimers	NULL
or	NULL
heterodimers	NULL
.	NULL

The	NULL
kind	NULL
of	NULL
dimer	NULL
is	NULL
determined	NULL
by	NULL
the	NULL
nuclear	NULL
composition	NULL
of	NULL
the	NULL
C/EBP	NULL
proteins	NULL
in	NULL
a	NULL
given	NULL
cell	NULL
and	NULL
dictates	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
distinct	NULL
set	NULL
of	NULL
genes	NULL
.	NULL

Thus	NULL
,	NULL
with	NULL
a	NULL
relatively	NULL
small	NULL
number	NULL
of	NULL
transcriptional	NULL
regulators	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
large	NULL
number	NULL
of	NULL
target	NULL
genes	NULL
can	NULL
be	NULL
tightly	NULL
controlled	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
interactions	NULL
between	NULL
C/EBP	NULL
members	NULL
and	NULL
CREB/ATF	NULL
(	NULL
13	NULL
)	NULL
,	NULL
Fos-Jun	NULL
family	NULL
(	NULL
14	NULL
)	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
may	NULL
occur	NULL
,	NULL
increasing	NULL
the	NULL
pool	NULL
of	NULL
available	NULL
interacting	NULL
transcription	NULL
factors	NULL
.	NULL

The	NULL
human	NULL
C/EBPs	NULL
gene	NULL
was	NULL
recently	NULL
cloned	NULL
and	NULL
its	NULL
location	NULL
assigned	NULL
to	NULL
chromosome	NULL
14	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

The	NULL
murine	NULL
C/EBPs	NULL
gene	NULL
is	NULL
located	NULL
on	NULL
mouse	NULL
chromosome	NULL
14	NULL
(	NULL
17	NULL
)	NULL
.	NULL

To	NULL
further	NULL
understand	NULL
the	NULL
role	NULL
of	NULL
C/EBPs	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
hematopoiesis	NULL
and	NULL
to	NULL
gain	NULL
insight	NULL
into	NULL
the	NULL
expression	NULL
and	NULL
function	NULL
of	NULL
C/EBPsz	NULL
,	NULL
we	NULL
have	NULL
determined	NULL
the	NULL
structural	NULL
organization	NULL
of	NULL
both	NULL
the	NULL
human	NULL
and	NULL
murine	NULL
C/EBPs	NULL
genes	NULL
.	NULL

Differential	NULL
splicing	NULL
and	NULL
alternative	NULL
use	NULL
of	NULL
promoters	NULL
in	NULL
the	NULL
human	NULL
locus	NULL
generates	NULL
a	NULL
total	NULL
of	NULL
four	NULL
C/EBPs	NULL
transcripts	NULL
of	NULL
2.6	NULL
kb	NULL
and	NULL
1.3-1.5	NULL
kb	NULL
in	NULL
size	NULL
.	NULL

These	NULL
transcripts	NULL
encode	NULL
three	NULL
proteins	NULL
of	NULL
calculated	NULL
molecular	NULL
mass	NULL
32.2	NULL
kDa	NULL
,	NULL
27.8	NULL
kDa	NULL
,	NULL
and	NULL
14.3	NULL
kDa	NULL
.	NULL

C/EBPs	NULL
mRNA	NULL
was	NULL
greatly	NULL
induced	NULL
during	NULL
in	NULL
vitro	NULL
granulocytic	NULL
differentiation	NULL
of	NULL
human	NULL
primary	NULL
CD34*	NULL
cells	NULL
.	NULL

Retinoic	NULL
acid	NULL
treatment	NULL
of	NULL
HL6O0	NULL
and	NULL
U937	NULL
cells	NULL
for	NULL
24	NULL
hr	NULL
induced	NULL
C/EBPs	NULL
mRNA	NULL
levels	NULL
by	NULL
approximately	NULL
4-fold	NULL
,	NULL
while	NULL
prolonged	NULL
treatment	NULL
gradually	NULL
reduced	NULL
mRNA	NULL
expression	NULL
to	NULL
pretreatment	NULL
levels	NULL
.	NULL

The	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
G-CSF	NULL
)	NULL
receptor	NULL
gene	NULL
is	NULL
a	NULL
critical	NULL
gene	NULL
for	NULL
myeloid	NULL
differentiation	NULL
,	NULL
particularly	NULL
for	NULL
the	NULL
production	NULL
of	NULL
neutrophils	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Transient	NULL
transfection	NULL
experiments	NULL
with	NULL
expression	NULL
vectors	NULL
for	NULL
two	NULL
C/EBPsz	NULL
protein	NULL
isoforms	NULL
and	NULL
the	NULL
myeloid-specific	NULL
G-CSF	NULL
receptor	NULL
promoter	NULL
reporter	NULL
gene	NULL
construct	NULL
,	NULL
suggest	NULL
a	NULL
role	NULL
for	NULL
C/EBPs	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
G-CSF	NULL
receptor	NULL
,	NULL
a	NULL
critical	NULL
gene	NULL
for	NULL
myelogenesis	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Isolation	NULL
of	NULL
Human	NULL
and	NULL
Murine	NULL
Genomic	NULL
and	NULL
cDNA	NULL
Clones	NULL
for	NULL
A	NULL
400-bp	NULL
Xhol/Pstl	NULL
and	NULL
a	NULL
403-bp	NULL
BamHI/Xbal	NULL
-labeled	NULL
human	NULL
cDNA	NULL
fragment	NULL
(	NULL
9	NULL
)	NULL
were	NULL
used	NULL
to	NULL
screen	NULL
a	NULL
Abbreviations	NULL
:	NULL
C/EBP	NULL
,	NULL
CCAAT/enhancer	NULL
binding	NULL
protein	NULL
;	NULL
G-CSF	NULL
,	NULL
granulocyte	NULL
colomy-stimulating	NULL
factor	NULL
;	NULL
M-CSF	NULL
,	NULL
monocyte	NULL
colony-stimulating	NULL
factor	NULL
;	NULL
bZIP	NULL
,	NULL
basic	NULL
region-leucine	NULL
zipper	NULL
;	NULL
RT	NULL
,	NULL
reverse	NULL
transcription	NULL
;	NULL
RACE	NULL
,	NULL
rapid	NULL
amplification	NULL
of	NULL
cDNA	NULL
ends	NULL
;	NULL
DMSO	NULL
,	NULL
dimethyl	NULL
sulfoxide	NULL
;	NULL
TPA	NULL
,	NULL
phorbol	NULL
12-tetradecanoate	NULL
13-acetate	NULL
.	NULL

$	NULL
To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

e-mail	NULL
:	NULL
kgx	NULL
@	NULL
nhgri.nih.gov	NULL
.	NULL

Medical	NULL
Sciences	NULL
:	NULL
Yamanaka	NULL
et	NULL
al	NULL
.	NULL

129/SVJ	NULL
genomic	NULL
mouse	NULL
library	NULL
(	NULL
Stratagene	NULL
)	NULL
and	NULL
several	NULL
cDNA	NULL
libraries	NULL
(	NULL
mouse	NULL
thymus	NULL
,	NULL
Stratagene	NULL
;	NULL
human	NULL
bone	NULL
marrow	NULL
,	NULL
mouse	NULL
spleen	NULL
,	NULL
mouse	NULL
7	NULL
day	NULL
embryo	NULL
,	NULL
CLONTECH	NULL
)	NULL
.	NULL

Phage	NULL
inserts	NULL
were	NULL
characterized	NULL
by	NULL
restriction	NULL
mapping	NULL
,	NULL
sequence	NULL
analysis	NULL
,	NULL
and	NULL
Southern	NULL
hybridization	NULL
.	NULL

5	NULL
'	NULL
Rapid	NULL
Amplification	NULL
of	NULL
cDNA	NULL
Ends	NULL
(	NULL
RACE	NULL
)	NULL
-PCR	NULL
,	NULL
Reverse	NULL
Transcription	NULL
(	NULL
RT	NULL
)	NULL
-PCR	NULL
,	NULL
and	NULL
Northern	NULL
Blot	NULL
Analysis	NULL
.	NULL

The	NULL
5	NULL
'	NULL
ends	NULL
of	NULL
both	NULL
the	NULL
Pa-	NULL
and	NULL
PB-initiated	NULL
transcripts	NULL
were	NULL
identified	NULL
using	NULL
a	NULL
5°	NULL
RACE	NULL
method	NULL
in	NULL
combination	NULL
with	NULL
the	NULL
Marathon	NULL
cDNA	NULL
amplification	NULL
kit	NULL
(	NULL
CLONTECH	NULL
)	NULL
.	NULL

The	NULL
C/EBPs-specific	NULL
oligonucleotide	NULL
primers	NULL
used	NULL
in	NULL
this	NULL
study	NULL
were	NULL
as	NULL
follows	NULL
(	NULL
see	NULL
also	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
:	NULL
RY	NULL
44	NULL
(	NULL
exon	NULL
I	NULL
«	NULL
specific	NULL
)	NULL
5'-GGA	NULL
AGG	NULL
CGT	NULL
GTC	NULL
AAG	NULL
GGA	NULL
GG-3	NULL
'	NULL
;	NULL
RY	NULL
46	NULL
(	NULL
exon	NULL
IB	NULL
specific	NULL
)	NULL
5'-	NULL
GCT	NULL
GGA	NULL
AGA	NULL
GAG	NULL
AAG	NULL
TGC	NULL
TG-3	NULL
'	NULL
;	NULL
RY	NULL
66	NULL
(	NULL
exon	NULL
Ia	NULL
specific	NULL
)	NULL
5	NULL
-ATG	NULL
TGT	NULL
GAG	NULL
CAT	NULL
GAG	NULL
GCC	NULL
TCC	NULL
ATT-3	NULL
'	NULL
;	NULL
RY	NULL
67	NULL
(	NULL
exon	NULL
IB	NULL
specific	NULL
)	NULL
5-CCT	NULL
CCC	NULL
TTG	NULL
ACA	NULL
CGC	NULL
CTT	NULL
CC-3	NULL
'	NULL
;	NULL
RY	NULL
68	NULL
(	NULL
internal	NULL
probe	NULL
)	NULL
5	NULL
-TGA	NULL
GAA	NULL
CGC	NULL
A	NULL
Human	NULL
C/EBPs	NULL
Locus	NULL
oe	NULL
!	NULL

Chidg11.2	NULL
hoa	NULL
s	NULL
a	NULL
AATAMRA	NULL
i	NULL
L	NULL
&	NULL
5	NULL
4	NULL
4	NULL
200	NULL
bp	NULL
ex	NULL
lo	NULL
.	NULL

ex	NULL
18	NULL
ex	NULL
lic	NULL
.	NULL

ex	NULL
B	NULL
ex	NULL
III	NULL
mRNA	NULL
size	NULL
|	NULL
Protein	NULL
size	NULL
Pal	NULL
2.2	NULL
kDa	NULL
.	NULL

Newwophts	NULL
:	NULL
reroin	NULL
266	NULL
*~	NULL
a	NULL
BMcDNA	NULL
ibay	NULL
worl	NULL
redvel	NULL
from	NULL
HLGO	NULL
13k	NULL
PE	NULL
ad	NULL
's	NULL
a	NULL
BM	NULL
cDNA	NULL
$	NULL
+RACE	NULL
genszaied	NULL
j	NULL
earl	NULL
AJn	NULL
1.5Kb	NULL
-	NULL
278	NULL
kDa	NULL
.	NULL

preducthomHLeo	NULL
Pos	NULL
kau	NULL
``	NULL
)	NULL
mBHA	NULL
:	NULL
net	NULL
found	NULL
in	NULL
a	NULL
BM	NULL
cDNA	NULL
Ibrary	NULL
Por	NULL
?	NULL

are	NULL
most	NULL
abundant	NULL
,	NULL
both	NULL
(	NULL
A	NULL
)	NULL
n	NULL
14	NULL
Kb	NULL
-	NULL
922kDa	NULL
.	NULL

in	NULL
BMandkHLeo	NULL
cDNA	NULL
branes	NULL
o	NULL
&	NULL
8	NULL
B	NULL
3	NULL
$	NULL
5	NULL
2	NULL
9	NULL
a	NULL
<	NULL
8	NULL
>	NULL
a	NULL
§	NULL
_	NULL
24G	NULL
$	NULL
%	NULL
3	NULL
o	NULL
C	NULL
0	NULL
%	NULL
=	NULL
Efidg	NULL
:	NULL
ffl	NULL
fifbii	NULL
:	NULL
if	NULL
c	NULL
I	NULL
oa	NULL
2	NULL
-	NULL
e-oarzs	NULL
-	NULL
$	NULL
-	NULL
2	NULL
$	NULL
58	NULL
¢	NULL
52	NULL
L	NULL
12000003	NULL
-	NULL
11007005	NULL
y*	NULL
``	NULL
>	NULL
Por	NULL
3	NULL
<	NULL
73	NULL
>	NULL
>	NULL
©	NULL
«	NULL
nm	NULL
«	NULL
»	NULL
sn	NULL
=	NULL
sss	NULL
»	NULL
Primers	NULL
3	NULL
&	NULL
5	NULL
Primers	NULL
3	NULL
&	NULL
5	NULL
Primers	NULL
3	NULL
&	NULL
5	NULL
Pod	NULL
p4	NULL
1826	NULL
bp	NULL
P	NULL
fual	NULL
Po2	NULL
<	NULL
w	NULL
»	NULL
tit	NULL
-	NULL
aum	NULL
641bp	NULL
Primers	NULL
1	NULL
&	NULL
5	NULL
Primers	NULL
1	NULL
&	NULL
5	NULL
Primers	NULL
1	NULL
&	NULL
5	NULL
<	NULL
r	NULL
Por	NULL
1439	NULL
bp	NULL
fud	NULL
«	NULL
‘	NULL
ﬂ-ﬂ	NULL
«	NULL
w	NULL
Pos	NULL
‘	NULL
565	NULL
bp	NULL
Primers	NULL
2	NULL
&	NULL
5	NULL
Primers	NULL
2	NULL
&	NULL
5	NULL
Primers	NULL
2	NULL
&	NULL
5	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

-	NULL
Modular	NULL
structure	NULL
of	NULL
the	NULL
C/EBPs	NULL
gene	NULL
and	NULL
its	NULL
distinct	NULL
RNA	NULL
transcripts	NULL
.	NULL

(	NULL
4	NULL
)	NULL
The	NULL
transcription	NULL
start	NULL
sites	NULL
of	NULL
each	NULL
of	NULL
the	NULL
two	NULL
promoters	NULL
,	NULL
Pa	NULL
and	NULL
P	NULL
B	NULL
,	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

Boxes	NULL
represent	NULL
coding	NULL
regions	NULL
and	NULL
thick	NULL
lines	NULL
represent	NULL
untranslated	NULL
regions	NULL
of	NULL
the	NULL
mature	NULL
mRNA	NULL
.	NULL

Nos	NULL
.	NULL

1-5	NULL
correspond	NULL
to	NULL
primers	NULL
R	NULL
Y46	NULL
,	NULL
R	NULL
Y44	NULL
,	NULL
RY66	NULL
,	NULL
RY68	NULL
,	NULL
and	NULL
R	NULL
Y77	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
location	NULL
of	NULL
the	NULL
relevant	NULL
start	NULL
codons	NULL
for	NULL
each	NULL
transcript	NULL
and	NULL
the	NULL
common	NULL
TGA	NULL
stop	NULL
codon	NULL
is	NULL
also	NULL
shown	NULL
.	NULL

Vertical	NULL
lines	NULL
in	NULL
the	NULL
bZIP	NULL
region	NULL
indicate	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
leucine	NULL
repeat	NULL
.	NULL

(	NULL
B	NULL
)	NULL
RT-PCR	NULL
reaction	NULL
products	NULL
amplified	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
C/EBPz	NULL
specific	NULL
primers	NULL
indicated	NULL
for	NULL
each	NULL
panel	NULL
were	NULL
analyzed	NULL
by	NULL
Southern	NULL
blotting	NULL
,	NULL
using	NULL
an	NULL
internal	NULL
primer	NULL
as	NULL
a	NULL
probe	NULL
(	NULL
primer	NULL
4	NULL
,	NULL
4	NULL
)	NULL
.	NULL

All	NULL
products	NULL
were	NULL
verified	NULL
by	NULL
sequence	NULL
.	NULL

B-Actin	NULL
specific	NULL
primers	NULL
were	NULL
used	NULL
as	NULL
controls	NULL
.	NULL

Fragment	NULL
sizes	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
right	NULL
,	NULL
and	NULL
the	NULL
name	NULL
of	NULL
each	NULL
transcript	NULL
is	NULL
at	NULL
the	NULL
left	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
primers	NULL
1	NULL
and	NULL
5	NULL
in	NULL
primary	NULL
T	NULL
cells	NULL
and	NULL
macrophages	NULL
amplifies	NULL
a	NULL
crossreacting	NULL
product	NULL
that	NULL
is	NULL
not	NULL
related	NULL
to	NULL
epsilon	NULL
based	NULL
on	NULL
sequence	NULL
analysis	NULL
of	NULL
this	NULL
fragment	NULL
(	NULL
Middle	NULL
)	NULL
.	NULL

A	NULL
Pal	NULL
RT-PCR-generated	NULL
fragment	NULL
of	NULL
1,826	NULL
bp	NULL
is	NULL
detected	NULL
with	NULL
longer	NULL
exposure	NULL
times	NULL
in	NULL
neutrophils	NULL
{	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
(	NULL
1997	NULL
)	NULL
6463	NULL
GCA	NULL
GAG	NULL
GCT	NULL
GGC-3	NULL
'	NULL
;	NULL
RY	NULL
72	NULL
(	NULL
exon	NULL
IIB	NULL
specific	NULL
)	NULL
5-TAG	NULL
CTC	NULL
CCT	NULL
GGG	NULL
CTG	NULL
CTG	NULL
TAG	NULL
ATG	NULL
CCA-3	NULL
'	NULL
;	NULL
RY	NULL
74	NULL
(	NULL
exon	NULL
Ha	NULL
specific	NULL
)	NULL
5-CCT	NULL
TGA	NULL
GCC	NULL
TTC	NULL
TGG	NULL
CCT	NULL
CAG	NULL
GCG	NULL
CTG-3	NULL
'	NULL
;	NULL
RY	NULL
77	NULL
(	NULL
exon	NULL
III	NULL
specific	NULL
)	NULL
5-CCC	NULL
CCC	NULL
ACG	NULL
CCC	NULL
TTG	NULL
ATG	NULL
AG-3	NULL
'	NULL
;	NULL
RY	NULL
79	NULL
(	NULL
exon	NULL
IIB	NULL
specific	NULL
)	NULL
5-GGC	NULL
TCC	NULL
TCC	NULL
TTC	NULL
ACC	NULL
ACC	NULL
ACA	NULL
GCC	NULL
CTG-3	NULL
'	NULL
;	NULL
and	NULL
RY	NULL
83	NULL
(	NULL
exon	NULL
IB	NULL
+	NULL
IIB	NULL
specific	NULL
)	NULL
5-CAG	NULL
CGC	NULL
CTT	NULL
CCT	NULL
GTC	NULL
TCC	NULL
TCC	NULL
CTT	NULL
GAC	NULL
ACG-3	NULL
'	NULL
.	NULL

We	NULL
constructed	NULL
cDNA	NULL
libraries	NULL
from	NULL
HL60	NULL
(	NULL
human	NULL
promyelocytic	NULL
leukemia	NULL
)	NULL
and	NULL
MNFS	NULL
60	NULL
[	NULL
myelogenous	NULL
leukemia	NULL
,	NULL
monocyte	NULL
CSF	NULL
(	NULL
M-CSF	NULL
)	NULL
-dependent	NULL
,	NULL
mouse	NULL
]	NULL
cell	NULL
lines	NULL
using	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
as	NULL
templates	NULL
.	NULL

The	NULL
PCR	NULL
primers	NULL
used	NULL
to	NULL
detect	NULL
C/EBPs	NULL
mRNA	NULL
expression	NULL
were	NULL
RY	NULL
66	NULL
,	NULL
RY	NULL
46	NULL
,	NULL
and	NULL
RY	NULL
44	NULL
in	NULL
combination	NULL
with	NULL
RY	NULL
77	NULL
.	NULL

Control	NULL
B-actin-specific	NULL
cDNA	NULL
primers	NULL
were	NULL
from	NULL
CLONTECH	NULL
.	NULL

mRNA	NULL
was	NULL
extracted	NULL
(	NULL
19	NULL
)	NULL
from	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
,	NULL
B	NULL
cells	NULL
,	NULL
neutrophils	NULL
and	NULL
macrophages	NULL
,	NULL
and	NULL
several	NULL
cell	NULL
lines	NULL
including	NULL
human	NULL
Molt-4	NULL
lymphoblastic	NULL
leukemia	NULL
,	NULL
KG1a	NULL
acute	NULL
myelogenous	NULL
leukemia	NULL
,	NULL
HL60	NULL
,	NULL
U937	NULL
monocytic	NULL
leukemia	NULL
,	NULL
RS4	NULL
;	NULL
11	NULL
t	NULL
(	NULL
4	NULL
;	NULL
11	NULL
)	NULL
acute	NULL
leukemia	NULL
and	NULL
Jurkat	NULL
acute	NULL
T	NULL
cell	NULL
leuke-mia	NULL
.	NULL

Human	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
from	NULL
bone	NULL
marrow	NULL
,	NULL
fetal	NULL
liver	NULL
,	NULL
lymph	NULL
node	NULL
,	NULL
spleen	NULL
,	NULL
and	NULL
thymus	NULL
(	NULL
CLONTECH	NULL
]	NULL
)	NULL
and	NULL
cell	NULL
lines	NULL
Daudi	NULL
,	NULL
Raji	NULL
Burkitt	NULL
lymphomas	NULL
,	NULL
and	NULL
K562	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
(	NULL
CLONTECH	NULL
]	NULL
)	NULL
were	NULL
also	NULL
used	NULL
as	NULL
templates	NULL
for	NULL
first-strand	NULL
synthesis	NULL
.	NULL

Northern	NULL
blots	NULL
with	NULL
approximately	NULL
20	NULL
ug	NULL
of	NULL
RNA	NULL
per	NULL
lane	NULL
were	NULL
hybridized	NULL
(	NULL
9	NULL
)	NULL
,	NULL
using	NULL
two	NULL
C/EBPs	NULL
specific	NULL
probes	NULL
:	NULL
a	NULL
3	NULL
'	NULL
terminal	NULL
500-bp	NULL
PstI	NULL
fragment	NULL
from	NULL
a	NULL
human	NULL
cDNA	NULL
clone	NULL
(	NULL
9	NULL
)	NULL
or	NULL
a	NULL
306-bp	NULL
PCR-generated	NULL
fragment	NULL
spanning	NULL
nucleotides	NULL
3,254	NULL
to	NULL
3,560	NULL
(	NULL
GenBank	NULL
no	NULL
.	NULL

U48865	NULL
)	NULL
.	NULL

To	NULL
assure	NULL
uniform	NULL
loading	NULL
,	NULL
the	NULL
blots	NULL
were	NULL
stripped	NULL
and	NULL
hybridized	NULL
to	NULL
oligonucle-otides	NULL
specific	NULL
for	NULL
either	NULL
the	NULL
188	NULL
RNA	NULL
,	NULL
nucleotides	NULL
938-921	NULL
(	NULL
20	NULL
)	NULL
,	NULL
or	NULL
288	NULL
RNA	NULL
,	NULL
nucleotides	NULL
4,036-4,020	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Primary	NULL
Cells	NULL
,	NULL
Cell	NULL
Lines	NULL
,	NULL
and	NULL
Transient	NULL
Transfection	NULL
Experiments	NULL
.	NULL

Human	NULL
primary	NULL
CD34*	NULL
cells	NULL
,	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
,	NULL
and	NULL
neutrophils	NULL
were	NULL
isolated	NULL
from	NULL
healthy	NULL
donors	NULL
as	NULL
described	NULL
(	NULL
22	NULL
)	NULL
.	NULL

CD34	NULL
*-enriched	NULL
cells	NULL
were	NULL
plated	NULL
in	NULL
human	NULL
myeloid	NULL
long-term	NULL
culture	NULL
medium	NULL
supplemented	NULL
with	NULL
300	NULL
units/ml	NULL
G-CSF	NULL
(	NULL
G	NULL
)	NULL
,	NULL
3	NULL
units/ml	NULL
erythropoietin	NULL
,	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
1	NULL
ng/ml	NULL
granulocyte-macrophage-CSF	NULL
and	NULL
200	NULL
ng/ml	NULL
M-CSF	NULL
(	NULL
GM	NULL
+	NULL
M	NULL
)	NULL
and	NULL
cultured	NULL
for	NULL
11	NULL
days	NULL
(	NULL
22	NULL
)	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
each	NULL
differentiation	NULL
experiment	NULL
cells	NULL
were	NULL
stained	NULL
by	NULL
the	NULL
Wright-Giemsa	NULL
method	NULL
,	NULL
and	NULL
differential	NULL
cell	NULL
counts	NULL
were	NULL
performed	NULL
.	NULL

U937	NULL
,	NULL
HL60	NULL
,	NULL
and	NULL
K562	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
medium	NULL
1640	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
and	NULL
2	NULL
nM	NULL
L-glutamine	NULL
.	NULL

To	NULL
induce	NULL
in	NULL
vitro	NULL
erythrocytic	NULL
differentiation	NULL
,	NULL
K562	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
medium	NULL
supplemented	NULL
with	NULL
1.5	NULL
%	NULL
dimethyl	NULL
]	NULL
sulfoxide	NULL
(	NULL
DMSO	NULL
)	NULL
for	NULL
up	NULL
to	NULL
5	NULL
days	NULL
.	NULL

U937	NULL
and	NULL
HL6O0	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
2	NULL
days	NULL
with	NULL
either	NULL
1.3	NULL
x	NULL
10-	NULL
``	NULL
M	NULL
phorbol	NULL
12-tetradecanoate	NULL
13-acetate	NULL
(	NULL
TPA	NULL
)	NULL
for	NULL
monocytic	NULL
differentiation	NULL
or	NULL
with	NULL
10~-°	NULL
M	NULL
retinoic	NULL
acid	NULL
for	NULL
4	NULL
days	NULL
to	NULL
induce	NULL
granulocytic	NULL
differentiation	NULL
.	NULL

HeLa	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
DMEM	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
and	NULL
were	NULL
transiently	NULL
transfected	NULL
at	NULL
70	NULL
%	NULL
confluency	NULL
by	NULL
liposome-mediated	NULL
transfection	NULL
reagent	NULL
DOTAP	NULL
(	NULL
N-	NULL
[	NULL
1-	NULL
(	NULL
2,3	NULL
)	NULL
-dioleoyloxy	NULL
)	NULL
propyl|-N	NULL
,	NULL
N	NULL
,	NULL
N-trimethylam-monium	NULL
methylsulfate	NULL
)	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
.	NULL

A	NULL
DNA	NULL
solution	NULL
containing	NULL
5	NULL
pg	NULL
of	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
pXP2	NULL
(	NULL
23	NULL
)	NULL
,	NULL
(	NULL
-74	NULL
to	NULL
+67	NULL
)	NULL
G-CSFR-pXP2	NULL
,	NULL
Mut	NULL
(	NULL
-74	NULL
to	NULL
+67	NULL
)	NULL
G-CSFR-pXP2	NULL
(	NULL
24	NULL
)	NULL
,	NULL
and	NULL
various	NULL
amounts	NULL
of	NULL
C/EBP	NULL
expression	NULL
vectors	NULL
(	NULL
pCMV-C/EBPa	NULL
,	NULL
pCMV-C/EBPs3	NULL
,	NULL
pCMV-C/EBP	NULL
s	NULL
!	NULL
``	NULL

)	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
B-galactosidase	NULL
reporter	NULL
plasmid	NULL
(	NULL
pCMV	NULL
B	NULL
)	NULL
and	NULL
pBluescript	NULL
KS	NULL
(	NULL
+	NULL
)	NULL
plasmid	NULL
DNA	NULL
to	NULL
adjust	NULL
to	NULL
a	NULL
total	NULL
of	NULL
10	NULL
ug	NULL
of	NULL
DNA	NULL
per	NULL
well	NULL
was	NULL
used	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
determined	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
25	NULL
)	NULL
,	NULL
and	NULL
transfection	NULL
efficiency	NULL
was	NULL
normalized	NULL
to	NULL
the	NULL
levels	NULL
of	NULL
B-galactosidase	NULL
expressed	NULL
from	NULL
1	NULL
ug	NULL
of	NULL
cotransfected	NULL
plasmid	NULL
.	NULL

6464	NULL
Medical	NULL
Sciences	NULL
:	NULL
Yamanaka	NULL
et	NULL
al	NULL
.	NULL

RESULTS	NULL
The	NULL
C/EBP£	NULL
Gene	NULL
Uses	NULL
Alternative	NULL
Promoters	NULL
and	NULL
Differential	NULL
Splicing	NULL
to	NULL
Generate	NULL
Several	NULL
RNA	NULL
Isoforms	NULL
.	NULL

Consistent	NULL
with	NULL
our	NULL
previously	NULL
described	NULL
results	NULL
(	NULL
9	NULL
)	NULL
,	NULL
Northern	NULL
blot	NULL
hybridization	NULL
using	NULL
RNA	NULL
from	NULL
immune	NULL
tissues	NULL
and	NULL
a	NULL
C/EBP	NULL
s-specific	NULL
probe	NULL
displayed	NULL
a	NULL
number	NULL
of	NULL
RNA	NULL
isoforms	NULL
of	NULL
predominantly	NULL
1.3-1.5	NULL
and	NULL
2.6	NULL
kb	NULL
in	NULL
size	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
analyze	NULL
each	NULL
transcript	NULL
isoform	NULL
in	NULL
detail	NULL
,	NULL
we	NULL
screened	NULL
a	NULL
variety	NULL
of	NULL
cDNA	NULL
and	NULL
genomic	NULL
libraries	NULL
to	NULL
isolate	NULL
the	NULL
human	NULL
and	NULL
the	NULL
murine	NULL
C/EBPs	NULL
genes	NULL
.	NULL

We	NULL
found	NULL
that	NULL
the	NULL
C/EBPs	NULL
gene	NULL
was	NULL
most	NULL
abundant	NULL
in	NULL
bone	NULL
marrow	NULL
and	NULL
HL60	NULL
cDNA	NULL
libraries	NULL
,	NULL
although	NULL
we	NULL
have	NULL
successfully	NULL
isolated	NULL
clones	NULL
from	NULL
mouse	NULL
thymus	NULL
and	NULL
MNSF	NULL
60	NULL
libraries	NULL
.	NULL

Clones	NULL
with	NULL
different	NULL
size	NULL
inserts	NULL
and	NULL
unique	NULL
or	NULL
overlapping	NULL
restriction	NULL
enzyme	NULL
patterns	NULL
were	NULL
isolated	NULL
and	NULL
sequenced	NULL
.	NULL

Several	NULL
murine	NULL
genomic	NULL
C/EBP	NULL
s	NULL
clones	NULL
were	NULL
also	NULL
isolated	NULL
,	NULL
covering	NULL
almost	NULL
35.5	NULL
kb	NULL
of	NULL
the	NULL
locus	NULL
.	NULL

We	NULL
focused	NULL
on	NULL
the	NULL
human	NULL
locus	NULL
and	NULL
identified	NULL
three	NULL
exons	NULL
by	NULL
comparing	NULL
genomic	NULL
and	NULL
cDNA	NULL
clone	NULL
sequences	NULL
and	NULL
by	NULL
RT-PCR	NULL
analysis	NULL
and	NULL
5°	NULL
RACE-PCR	NULL
using	NULL
a	NULL
variety	NULL
of	NULL
oligonucleotide	NULL
combinations	NULL
and	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
templates	NULL
.	NULL

A	NULL
schematic	NULL
map	NULL
of	NULL
the	NULL
human	NULL
C/EBP	NULL
s	NULL
locus	NULL
and	NULL
all	NULL
of	NULL
the	NULL
C/EBPs	NULL
RNA	NULL
transcripts	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
.	NULL

RNA	NULL
was	NULL
extracted	NULL
from	NULL
a	NULL
variety	NULL
of	NULL
cells	NULL
to	NULL
identify	NULL
the	NULL
exon	NULL
composition	NULL
of	NULL
each	NULL
transcript	NULL
by	NULL
RT-PCR	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
the	NULL
PCR	NULL
products	NULL
were	NULL
correctly	NULL
amplified	NULL
from	NULL
a	NULL
C/EBP	NULL
s	NULL
template	NULL
,	NULL
Southern	NULL
blot	NULL
experiments	NULL
were	NULL
performed	NULL
using	NULL
an	NULL
internal	NULL
C/EBPs	NULL
specific	NULL
primer	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

A	NULL
representative	NULL
set	NULL
of	NULL
results	NULL
from	NULL
such	NULL
RT-PCR	NULL
assays	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
with	NULL
the	NULL
expected	NULL
size	NULL
shown	NULL
on	NULL
the	NULL
right	NULL
.	NULL

mRNA	NULL
from	NULL
bone	NULL
marrow	NULL
,	NULL
neutrophils	NULL
,	NULL
and	NULL
HL60	NULL
cells	NULL
amplified	NULL
several	NULL
C/EBPs	NULL
fragments	NULL
corresponding	NULL
to	NULL
C/EBPs	NULL
isoforms	NULL
,	NULL
as	NULL
did	NULL
mRNA	NULL
from	NULL
spleen	NULL
,	NULL
fetal	NULL
liver	NULL
,	NULL
U937	NULL
,	NULL
RS4	NULL
;	NULL
11	NULL
,	NULL
Molt4	NULL
,	NULL
and	NULL
Daudi	NULL
cells	NULL
A	NULL
nonspecific	NULL
RT-PCR-amplified	NULL
product	NULL
was	NULL
detected	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
macrophages	NULL
when	NULL
primers	NULL
1	NULL
and	NULL
5	NULL
were	NULL
used	NULL
in	NULL
combination	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
sequence	NULL
analysis	NULL
revealed	NULL
that	NULL
this	NULL
fragment	NULL
is	NULL
not	NULL
related	NULL
to	NULL
C/EBPs	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
several	NULL
differentially	NULL
spliced	NULL
C/EBPs	NULL
mRNA	NULL
species	NULL
was	NULL
confirmed	NULL
by	NULL
the	NULL
isolation	NULL
of	NULL
27	NULL
cDNA	NULL
clones	NULL
obtained	NULL
from	NULL
a	NULL
human	NULL
bone	NULL
marrow	NULL
cDNA	NULL
library	NULL
.	NULL

The	NULL
last	NULL
exon	NULL
encoding	NULL
the	NULL
bZIP	NULL
domain	NULL
was	NULL
present	NULL
in	NULL
all	NULL
cDNA	NULL
clones	NULL
;	NULL
however	NULL
,	NULL
several	NULL
differences	NULL
were	NULL
found	NULL
in	NULL
the	NULL
5	NULL
'	NULL
end	NULL
regions	NULL
of	NULL
the	NULL
inserts	NULL
.	NULL

Pa3	NULL
contains	NULL
exon	NULL
1	NULL
,	NULL
which	NULL
is	NULL
436	NULL
bp	NULL
long	NULL
and	NULL
includes	NULL
two	NULL
in-frame	NULL
AUG	NULL
initiation	NULL
codons	NULL
that	NULL
are	NULL
separated	NULL
by	NULL
3	NULL
bp	NULL
(	NULL
see	NULL
also	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Pa2	NULL
and	NULL
Pa3	NULL
differ	NULL
in	NULL
that	NULL
they	NULL
use	NULL
two	NULL
different	NULL
splice	NULL
donor	NULL
sites	NULL
in	NULL
exon	NULL
1	NULL
to	NULL
splice	NULL
to	NULL
the	NULL
same	NULL
acceptor	NULL
site	NULL
in	NULL
exon	NULL
2	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
4	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
last	NULL
exon	NULL
of	NULL
334	NULL
bp	NULL
,	NULL
contains	NULL
the	NULL
bZIP	NULL
domain	NULL
of	NULL
the	NULL
molecule	NULL
and	NULL
is	NULL
present	NULL
in	NULL
all	NULL
C/EBPs	NULL
isoforms	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
start	NULL
site	NULL
of	NULL
the	NULL
bone	NULL
marrow	NULL
cDNA	NULL
clones	NULL
we	NULL
performed	NULL
5	NULL
'	NULL
RACE	NULL
assays	NULL
.	NULL

Sequence	NULL
analysis	NULL
of	NULL
the	NULL
bone	NULL
marrow	NULL
cDNA	NULL
clones	NULL
and	NULL
5	NULL
'	NULL
RACE	NULL
from	NULL
mRNA	NULL
derived	NULL
from	NULL
HL60	NULL
cells	NULL
confirmed	NULL
that	NULL
they	NULL
were	NULL
genuine	NULL
products	NULL
of	NULL
differentially	NULL
spliced	NULL
RNA	NULL
transcripts	NULL
.	NULL

The	NULL
start	NULL
site	NULL
identified	NULL
in	NULL
these	NULL
clones	NULL
was	NULL
different	NULL
due	NULL
to	NULL
the	NULL
alternate	NULL
use	NULL
of	NULL
two	NULL
promoters	NULL
,	NULL
Pa	NULL
and	NULL
PB	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
differential	NULL
splicing	NULL
,	NULL
alternative	NULL
use	NULL
of	NULL
promoters	NULL
also	NULL
contributes	NULL
to	NULL
the	NULL
differences	NULL
at	NULL
the	NULL
5	NULL
'	NULL
end	NULL
region	NULL
.	NULL

Several	NULL
5°	NULL
RACE-PCR	NULL
independent	NULL
clones	NULL
were	NULL
sequenced	NULL
to	NULL
determine	NULL
the	NULL
initiation	NULL
nucleotides	NULL
shown	NULL
for	NULL
each	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
arrows	NULL
)	NULL
.	NULL

The	NULL
equivalent	NULL
promoter	NULL
regions	NULL
of	NULL
human	NULL
and	NULL
murine	NULL
genes	NULL
were	NULL
very	NULL
conserved	NULL
around	NULL
the	NULL
PB	NULL
promoter	NULL
but	NULL
not	NULL
the	NULL
Pa	NULL
promoter	NULL
region	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Both	NULL
Pa	NULL
and	NULL
PB	NULL
promoter	NULL
regions	NULL
lack	NULL
any	NULL
obvious	NULL
TATAAA	NULL
or	NULL
CAAT-like	NULL
motifs	NULL
.	NULL

Similar	NULL
to	NULL
other	NULL
TATA-less	NULL
promoter	NULL
regions	NULL
of	NULL
genes	NULL
expressed	NULL
in	NULL
the	NULL
hematopoietic	NULL
system	NULL
,	NULL
a	NULL
number	NULL
of	NULL
purine-rich	NULL
stretches	NULL
lie	NULL
upstream	NULL
of	NULL
both	NULL
start	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Several	NULL
sites	NULL
for	NULL
the	NULL
consensus	NULL
sequences	NULL
for	NULL
PU.1	NULL
(	NULL
an	NULL
ets	NULL
factor	NULL
)	NULL
RRR-GAGGAAG	NULL
were	NULL
also	NULL
found	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
(	NULL
1997	NULL
)	NULL
Po-promoter	NULL
accagagcagqtgtctctagtcc	NULL
187	NULL
Eee	NULL
|	NULL
.	NULL

-123	NULL
octggagacectaaaacagagecocagqasqaeqg	NULL
]	NULL
ca	NULL
tgaca	NULL
thadaggkt	NULL
tat	NULL
caaacetgac	NULL
59	NULL
agacccacgcatttcggcca	NULL
gcdasaggaaaGac	NULL
+5	NULL
agraadeqaqgetgcagcaagetectaagecctqeageccaggcacagqgaaaccagaggcagage	NULL
+69	NULL
+133	NULL
agagaagtgeotygagccaceqqaggattatggctgtctactcogaguqcagcaace	NULL
Lgectagg	NULL
+157	NULL
ocbgeggtgcaaggoccaagtockgaccaggtqctt	NULL
Eggccaageccagggagtaggaagtg't	NULL
+261	NULL
accaggctgctagaggtagctaqggctggaaacgcactaatatttgggctattgcacagctcct	NULL
+325	NULL
gtgcaaaaacctagcaaATGAGCATGCTC	NULL
PB-promoter	NULL
[	NULL
Gegaggbattoodaga	NULL
@	NULL
ghatcagettoggycatetccagaacocktgy	NULL
-	NULL
~195	NULL
cttggtcoctgaccBaggaghbyctccaachygetgaataggecaggagtogectttetotaagge	NULL
131	NULL
ttacaberotocotobguggtotgtoctqcoecctcoc	NULL
Lgagtcaccecchaggegagedacaoge	NULL
]	NULL
~67	NULL
-	NULL
-	NULL
>	NULL
agagaquccacacaggag	NULL
tqqytgacagaggagactycagaggqcagg	NULL
tc	NULL
tagggcagaagate	NULL
+62	NULL
gagagaggycaggoccagy	NULL
Lcageaqggaggtagagagag	NULL
@	NULL
ycagcoggagcacoccaagqggte	NULL
-	NULL
+126	NULL
oct	NULL
caagagcage	NULL
+194	NULL
ACGACTGTEAGCCCCGECCTECCCACCACTCeAGTTCTCACeSeeCCeaccTececccstccac	NULL
+258	NULL
CTAGCGGACATGTGTGAGC	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Sequence	NULL
of	NULL
the	NULL
two	NULL
putative	NULL
human	NULL
C/EBPs	NULL
promoter	NULL
regions	NULL
.	NULL

The	NULL
PB	NULL
region	NULL
is	NULL
the	NULL
major	NULL
promoter	NULL
used	NULL
in	NULL
HL6O	NULL
cells	NULL
,	NULL
because	NULL
the	NULL
majority	NULL
of	NULL
the	NULL
clones	NULL
(	NULL
>	NULL
60	NULL
%	NULL
)	NULL
identified	NULL
by	NULL
RACE-PCR	NULL
were	NULL
initiated	NULL
at	NULL
this	NULL
site	NULL
.	NULL

The	NULL
transcriptional	NULL
start	NULL
sites	NULL
of	NULL
the	NULL
C/EBPs	NULL
gene	NULL
were	NULL
determined	NULL
by	NULL
5'-RACE-PCR	NULL
and	NULL
sequence	NULL
analysis	NULL
of	NULL
several	NULL
independent	NULL
clones	NULL
.	NULL

Large	NULL
arrows	NULL
indicate	NULL
sequence	NULL
ends	NULL
of	NULL
the	NULL
majority	NULL
of	NULL
cDNA	NULL
clones	NULL
for	NULL
each	NULL
promoter	NULL
region	NULL
.	NULL

Small	NULL
arrows	NULL
show	NULL
ends	NULL
of	NULL
less	NULL
frequent	NULL
RACE-PCR	NULL
clones	NULL
.	NULL

The	NULL
translation	NULL
initiation	NULL
codon	NULL
is	NULL
shown	NULL
in	NULL
uppercase	NULL
and	NULL
bold	NULL
characters	NULL
.	NULL

Purine	NULL
stretches	NULL
are	NULL
boxed	NULL
.	NULL

Three	NULL
Proteins	NULL
Are	NULL
Encoded	NULL
by	NULL
the	NULL
C/EBP	NULL
:	NULL
Gene	NULL
with	NULL
Identical	NULL
bZIP	NULL
Domains	NULL
.	NULL

C/EBP	NULL
s	NULL
protein	NULL
was	NULL
detected	NULL
in	NULL
cell	NULL
lines	NULL
of	NULL
hematopoietic	NULL
origin	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
a	NULL
peptide	NULL
antibody	NULL
to	NULL
the	NULL
C-terminal	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

Multiple	NULL
size	NULL
proteins	NULL
were	NULL
detected	NULL
in	NULL
MNFS	NULL
60	NULL
,	NULL
U937	NULL
,	NULL
and	NULL
HL60	NULL
.	NULL

The	NULL
L	NULL
30	NULL
21.5	NULL
14.3	NULL
c/EBPe	NULL
Z	NULL
;	NULL
oryysCEpRGGqOOPLEFSGCRACPCELCDNCERFASIDLEAYIESCEEQLLSDLFAY	NULL
50	NULL
oneBre	NULL
2	NULL
``	NULL
inmsmmpacy®LVPRTYHYSLOPSXNKPWPTLRECSCRWCYERNFLLOVecAcceeRa	NULL
60	NULL
c/eBre	NULL
-	NULL
h	NULL
32	NULL
C/EBPC	NULL
O.	NULL
KPAPEARRLKGPGTPAFPHYLPPDPRPFAYPPHTFGEDRKALGPGIYSSPGSYDPRAVAV|	NULL
.	NULL

120	NULL
C/RBBE	NULL
T1	NULL
.	NULL

ono	NULL
Ipexanapetyssresyppravayl	NULL
|	NULL
120	NULL
c/sare	NULL
0	NULL
c/sere	NULL
32	NULL
c/zare	NULL
2	NULL
``	NULL
c/sare	NULL
**	NULL
Ik=mprobresraaSRGSYNPIQYOVARCGOTAMHLPPTLAAPGOPLRVLKAPLATAAPPC|	NULL
-	NULL
151	NULL
————————————————————————————————	NULL
MHLPPTLAAPGOPLRYLEAPLATAAPPC	NULL
28	NULL
IKEEPRGPEGSRAASRGSVNP1	NULL
PGO	NULL
PLRVLXAPLATAAPPC	NULL
‘	NULL
180	NULL
c/sare	NULL
32	NULL
c/sare	NULL
2	NULL
``	NULL
c/mare	NULL
4	NULL
SPLLKAPS	NULL
PAGPLEKCKKAVNEDSLEYRLRRERNNTAVRKSRDKAKRE	NULL
I	NULL
LETOOXVLEYM	NULL
SPLLKAPS	NULL
PAGPLHKCKKAVNKDSLREYRLRRERNNTAVRKSRDKAXRR	NULL
ILETOOKVLEXM	NULL
SPLLKA	NULL
PS	NULL
PAGPLHKGKKAVNEDS	NULL
LEYRLRRERNNIAVRESRDKAKRR	NULL
I	NULL
LETOOKVLEXM	NULL
240	NULL
211	NULL
88	NULL
32	NULL
c/zBre	NULL
2	NULL
``	NULL
e	NULL
c	NULL
281	NULL
252	NULL
129	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

-	NULL
Three	NULL
proteins	NULL
with	NULL
identical	NULL
bZIP	NULL
domains	NULL
are	NULL
encoded	NULL
by	NULL
the	NULL
C/EBPz	NULL
gene	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
cell	NULL
lines	NULL
.	NULL

Equivalent	NULL
amounts	NULL
of	NULL
cell	NULL
extracts	NULL
from	NULL
each	NULL
of	NULL
the	NULL
cell	NULL
lines	NULL
shown	NULL
were	NULL
loaded	NULL
.	NULL

Molecular	NULL
mass	NULL
markers	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
left	NULL
side	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
three	NULL
proteins	NULL
C/EBP	NULL
s*	NULL
,	NULL
C/EBPs*	NULL
``	NULL
,	NULL
and	NULL
C/EBPs	NULL
!	NULL

*	NULL
are	NULL
shown	NULL
.	NULL

Boxed	NULL
residues	NULL
represent	NULL
identical	NULL
amino	NULL
acids	NULL
.	NULL

®	NULL
indicate	NULL
the	NULL
position	NULL
of	NULL
each	NULL
leucine	NULL
residue	NULL
of	NULL
the	NULL
zipper	NULL
.	NULL

Medical	NULL
Sciences	NULL
:	NULL
Yamanaka	NULL
et	NULL
al	NULL
.	NULL

four	NULL
mRNA	NULL
isoforms	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
can	NULL
give	NULL
rise	NULL
to	NULL
three	NULL
proteins	NULL
that	NULL
have	NULL
the	NULL
same	NULL
basic	NULL
DNA-binding	NULL
domain	NULL
but	NULL
differ	NULL
in	NULL
the	NULL
N-terminal	NULL
part	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

A	NULL
band	NULL
of	NULL
varying	NULL
intensity	NULL
between	NULL
experiments	NULL
was	NULL
also	NULL
detected	NULL
around	NULL
30	NULL
kDa	NULL
.	NULL

It	NULL
may	NULL
represent	NULL
a	NULL
degradation	NULL
product	NULL
of	NULL
the	NULL
larger	NULL
protein	NULL
or	NULL
a	NULL
nonspecific	NULL
cross-reacting	NULL
protein	NULL
.	NULL

There	NULL
are	NULL
five	NULL
in-frame	NULL
AUG	NULL
codons	NULL
,	NULL
but	NULL
only	NULL
three	NULL
satisfy	NULL
the	NULL
Kozak	NULL
context	NULL
GCC	NULL
(	NULL
A/G	NULL
)	NULL
CCAUGG	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Transcripts	NULL
Pal	NULL
and	NULL
PBI	NULL
have	NULL
identical	NULL
reading	NULL
frames	NULL
with	NULL
an	NULL
ORF	NULL
of	NULL
281	NULL
amino	NULL
acids	NULL
and	NULL
have	NULL
the	NULL
capacity	NULL
to	NULL
generate	NULL
two	NULL
proteins	NULL
of	NULL
32.2	NULL
kDa	NULL
and	NULL
27.3	NULL
kDa	NULL
.	NULL

There	NULL
is	NULL
another	NULL
in-frame	NULL
AUG	NULL
codon	NULL
32	NULL
amino	NULL
residues	NULL
downstream	NULL
of	NULL
the	NULL
first	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
,	NULL
However	NULL
,	NULL
initiation	NULL
of	NULL
translation	NULL
at	NULL
this	NULL
downstream	NULL
codon	NULL
is	NULL
less	NULL
likely	NULL
because	NULL
of	NULL
an	NULL
imperfect	NULL
match	NULL
to	NULL
the	NULL
Kozak	NULL
context	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
vitro	NULL
transcription-translation	NULL
assays	NULL
in	NULL
rabbit	NULL
reticulocyte	NULL
lysates	NULL
strongly	NULL
favors	NULL
initiation	NULL
at	NULL
the	NULL
first	NULL
AUG	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Transcripts	NULL
Pa2	NULL
and	NULL
Pa3	NULL
can	NULL
generate	NULL
two	NULL
proteins	NULL
of	NULL
27.8	NULL
kDa	NULL
and	NULL
14.3	NULL
kDa	NULL
with	NULL
the	NULL
same	NULL
basic	NULL
domain	NULL
as	NULL
the	NULL
previous	NULL
proteins	NULL
.	NULL

Both	NULL
AUG	NULL
codons	NULL
lie	NULL
in	NULL
a	NULL
relatively	NULL
strong	NULL
Kozak	NULL
context	NULL
.	NULL

Thus	NULL
,	NULL
several	NULL
proteins	NULL
can	NULL
be	NULL
encoded	NULL
by	NULL
the	NULL
C/EBP	NULL
sz	NULL
gene	NULL
,	NULL
and	NULL
these	NULL
proteins	NULL
can	NULL
be	NULL
detected	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
in	NULL
MNFS60	NULL
,	NULL
U937	NULL
,	NULL
and	NULL
HL60	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

Two	NULL
of	NULL
the	NULL
protein	NULL
isoforms	NULL
(	NULL
32.3	NULL
kDa	NULL
and	NULL
14.3	NULL
kDa	NULL
)	NULL
were	NULL
used	NULL
for	NULL
transfection	NULL
experiments	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
(	NULL
1997	NULL
)	NULL
6465	NULL
Induction	NULL
of	NULL
C/EBPE	NULL
mRNA	NULL
Expression	NULL
Correlates	NULL
with	NULL
Granulocytic	NULL
Differentiation	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
RNA	NULL
extracted	NULL
from	NULL
human	NULL
primary	NULL
CD34	NULL
*	NULL
cells	NULL
showed	NULL
that	NULL
early	NULL
progenitor	NULL
cells	NULL
do	NULL
not	NULL
express	NULL
significant	NULL
levels	NULL
of	NULL
C/EBPs	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
day	NULL
0	NULL
)	NULL
.	NULL

To	NULL
test	NULL
for	NULL
steady-state	NULL
C/EBPs	NULL
mRNA	NULL
levels	NULL
during	NULL
in	NULL
vitro	NULL
differentiation	NULL
of	NULL
primary	NULL
human	NULL
CD34	NULL
*	NULL
cells	NULL
enriched	NULL
from	NULL
peripheral	NULL
blood	NULL
of	NULL
healthy	NULL
donors	NULL
,	NULL
cells	NULL
were	NULL
plated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
GM-CSF	NULL
and	NULL
M-CSF	NULL
(	NULL
GM	NULL
+	NULL
M	NULL
)	NULL
,	NULL
G-CSF	NULL
(	NULL
G	NULL
)	NULL
or	NULL
erythropoietin	NULL
(	NULL
Epo	NULL
)	NULL
.	NULL

C/EBPs	NULL
gene	NULL
expression	NULL
was	NULL
detected	NULL
in	NULL
granulocytic	NULL
cells	NULL
after	NULL
8	NULL
days	NULL
of	NULL
culture	NULL
and	NULL
was	NULL
greatly	NULL
induced	NULL
at	NULL
day	NULL
11	NULL
of	NULL
differentiation	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
G	NULL
,	NULL
8	NULL
and	NULL
11	NULL
)	NULL
.	NULL

Control	NULL
hybridizations	NULL
of	NULL
the	NULL
same	NULL
blot	NULL
shows	NULL
that	NULL
the	NULL
RNA	NULL
samples	NULL
in	NULL
these	NULL
two	NULL
lanes	NULL
have	NULL
migrated	NULL
evenly	NULL
(	NULL
288	NULL
control	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
careful	NULL
comparison	NULL
between	NULL
the	NULL
two	NULL
hybridizing	NULL
bands	NULL
at	NULL
8	NULL
and	NULL
11	NULL
indicated	NULL
that	NULL
the	NULL
RNA	NULL
form	NULL
at	NULL
day	NULL
11	NULL
is	NULL
larger	NULL
,	NULL
possibly	NULL
corresponding	NULL
to	NULL
a	NULL
different	NULL
C/EBP	NULL
isoform	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

In	NULL
accordance	NULL
with	NULL
the	NULL
5'-RACE	NULL
results	NULL
RNA	NULL
extracted	NULL
from	NULL
HL60	NULL
cells	NULL
displays	NULL
multiple	NULL
C/EBPzs	NULL
RNA	NULL
isoforms	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
;	NULL
lane	NULL
marked	NULL
HL60	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
mature	NULL
human	NULL
neutrophils	NULL
purified	NULL
from	NULL
peripheral	NULL
blood	NULL
of	NULL
healthy	NULL
donors	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
the	NULL
long	NULL
Pal	NULL
isoform	NULL
of	NULL
C/EBPs	NULL
whereas	NULL
human	NULL
monocytes	NULL
do	NULL
not	NULL
express	NULL
any	NULL
detectable	NULL
amounts	NULL
of	NULL
C/EBPs	NULL
mRNA	NULL
.	NULL

We	NULL
also	NULL
tested	NULL
whether	NULL
C/EBPs	NULL
is	NULL
induced	NULL
during	NULL
granulocytic	NULL
differentiation	NULL
of	NULL
several	NULL
human	NULL
leukemic	NULL
cell	NULL
lines	NULL
.	NULL

sex	NULL
w	NULL
»	NULL
A	NULL
E	NULL
B	NULL
as	NULL
|_	NULL
T	NULL
<	NULL
8	NULL
2	NULL
o	NULL
¢	NULL
EEE	NULL
Gm	NULL
5	NULL
T	NULL
E	NULL
2	NULL
T	NULL
300	NULL
iM	NULL
G	NULL
Epo	NULL
on	NULL
a	NULL
o§f€l—u—-|r—-—|38ﬁ	NULL
¥	NULL
8	NULL
0	NULL
8	NULL
11	NULL
8	NULL
11	NULL
8	NULL
11	NULL
T	NULL
D	NULL
T	NULL
28	NULL
S	NULL
-jg8-	NULL
¥	NULL
P	NULL
hC/EBPe	NULL
185	NULL
-	NULL
®®	NULL
__	NULL
Ou	NULL
:	NULL
:	NULL
¥	NULL
«	NULL
-	NULL
w	NULL
28	NULL
S	NULL
c	NULL
K562	NULL
U937	NULL
HL6O	NULL
I	NULL
I	NULL
H	NULL
1	NULL
+	NULL
DMSO	NULL
+TPA	NULL
+	NULL
RA	NULL
+TPA	NULL
+	NULL
RA	NULL
I	NULL
L.	NULL
I	NULL
I	NULL
H	NULL
1	NULL
I	NULL
I	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
2	NULL
1	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
2	NULL
1	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
days	NULL
285	NULL
==	NULL
188	NULL
==	NULL
I	NULL
=	NULL
v	NULL
o	NULL
0	NULL
=a	NULL
»	NULL
y	NULL
#	NULL
#	NULL
a	NULL
®	NULL
w	NULL
--	NULL
hC/EBPs	NULL
18	NULL
S	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

(	NULL
4	NULL
)	NULL
C/EBPe	NULL
mRNA	NULL
is	NULL
preferentially	NULL
expressed	NULL
in	NULL
granulocytic	NULL
cells	NULL
.	NULL

Primary	NULL
human	NULL
CD34	NULL
*	NULL
cells	NULL
were	NULL
enriched	NULL
from	NULL
peripheral	NULL
blood	NULL
of	NULL
healthy	NULL
donors	NULL
and	NULL
plated	NULL
in	NULL
medium	NULL
supplemented	NULL
with	NULL
GM-CSF	NULL
and	NULL
M-CSF	NULL
(	NULL
GM	NULL
+	NULL
M	NULL
;	NULL
lanes	NULL
4-5	NULL
)	NULL
,	NULL
G-CSF	NULL
(	NULL
G	NULL
;	NULL
lanes	NULL
6-7	NULL
)	NULL
,	NULL
or	NULL
erythropoietin	NULL
(	NULL
Epo	NULL
,	NULL
lanes	NULL
8-9	NULL
)	NULL
.	NULL

Northern	NULL
blot	NULL
was	NULL
performed	NULL
after	NULL
8	NULL
days	NULL
(	NULL
lanes	NULL
4	NULL
,	NULL
6	NULL
,	NULL
8	NULL
)	NULL
and	NULL
11	NULL
days	NULL
(	NULL
lanes	NULL
5	NULL
,	NULL
7	NULL
,	NULL
9	NULL
)	NULL
of	NULL
culture	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
KG1a	NULL
cells	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
enriched	NULL
CD34+*	NULL
cells	NULL
(	NULL
83	NULL
%	NULL
CD34+*	NULL
)	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
primary	NULL
CD34*	NULL
cells	NULL
(	NULL
CD34+	NULL
)	NULL
used	NULL
for	NULL
in	NULL
vitro	NULL
differentiation	NULL
(	NULL
lanes	NULL
4-9	NULL
)	NULL
;	NULL
lane	NULL
10	NULL
,	NULL
HL6O0	NULL
cells	NULL
.	NULL

(	NULL
Upper	NULL
)	NULL
Hybridization	NULL
to	NULL
a	NULL
C/EBP	NULL
-specific	NULL
probe	NULL
.	NULL

(	NULL
Lower	NULL
)	NULL
The	NULL
blot	NULL
was	NULL
stripped	NULL
and	NULL
hybridized	NULL
to	NULL
a	NULL
285	NULL
RNA	NULL
oligonucleotide	NULL
control	NULL
probe	NULL
.	NULL

(	NULL
#	NULL
)	NULL
Mature	NULL
human	NULL
neutrophils	NULL
express	NULL
the	NULL
long	NULL
isoform	NULL
of	NULL
C/EBPz	NULL
.	NULL

Human	NULL
monocytes	NULL
and	NULL
neutrophils	NULL
were	NULL
purified	NULL
from	NULL
peripheral	NULL
blood	NULL
of	NULL
healthy	NULL
donors	NULL
.	NULL

HeLa	NULL
cells	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
human	NULL
monocytes	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
human	NULL
neutrophils	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
and	NULL
HL60	NULL
cells	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

Migration	NULL
of	NULL
the	NULL
28S	NULL
and	NULL
188	NULL
ribosomal	NULL
RNA	NULL
is	NULL
shown	NULL
to	NULL
the	NULL
left	NULL
.	NULL

(	NULL
C	NULL
)	NULL
C/EBPsz	NULL
is	NULL
up-regulated	NULL
during	NULL
granulocytic	NULL
differentiation	NULL
of	NULL
human	NULL
leukemic	NULL
cell	NULL
lines	NULL
.	NULL

K562	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
medium	NULL
supplemented	NULL
with	NULL
1.5	NULL
%	NULL
DMSO	NULL
(	NULL
+DMSO	NULL
)	NULL
for	NULL
5	NULL
days	NULL
to	NULL
induce	NULL
erythrocytic	NULL
differentiation	NULL
.	NULL

U937	NULL
and	NULL
HL60	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
2	NULL
days	NULL
with	NULL
1.3	NULL
X	NULL
10~	NULL
'	NULL
M	NULL
TPA	NULL
(	NULL
+TPA	NULL
)	NULL
for	NULL
monocytic	NULL
differentiation	NULL
or	NULL
with	NULL
107°	NULL
M	NULL
retinoic	NULL
acid	NULL
(	NULL
+RA	NULL
)	NULL
for	NULL
4	NULL
days	NULL
for	NULL
granulocytic	NULL
differentiation	NULL
.	NULL

Northern	NULL
blot	NULL
was	NULL
performed	NULL
at	NULL
time	NULL
points	NULL
indicated	NULL
above	NULL
each	NULL
lane	NULL
,	NULL
as	NULL
described	NULL
above	NULL
with	NULL
the	NULL
exception	NULL
that	NULL
RNA	NULL
was	NULL
normalized	NULL
to	NULL
188	NULL
ribosomal	NULL
RNA	NULL
(	NULL
Lower	NULL
)	NULL
.	NULL

6466	NULL
Medical	NULL
Sciences	NULL
:	NULL
Yamanaka	NULL
et	NULL
al	NULL
.	NULL

K562	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
1.5	NULL
%	NULL
DMSO	NULL
for	NULL
5	NULL
days	NULL
to	NULL
induce	NULL
erythrocytic	NULL
differentiation	NULL
;	NULL
U937	NULL
and	NULL
HL60	NULL
cells	NULL
were	NULL
treated	NULL
either	NULL
with	NULL
1.3	NULL
X	NULL
10-	NULL
``	NULL
M	NULL
TPA	NULL
to	NULL
induce	NULL
monocytic	NULL
differentiation	NULL
for	NULL
2	NULL
days	NULL
,	NULL
or	NULL
with	NULL
10~°	NULL
M	NULL
retinoic	NULL
acid	NULL
for	NULL
4	NULL
days	NULL
for	NULL
granulocytic	NULL
differentiation	NULL
.	NULL

No	NULL
expression	NULL
of	NULL
C/EBPs	NULL
mRNA	NULL
was	NULL
detected	NULL
in	NULL
DMSO-treated	NULL
or	NULL
untreated	NULL
K562	NULL
cells	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
results	NULL
obtained	NULL
from	NULL
the	NULL
erythroid	NULL
differentiation	NULL
of	NULL
primary	NULL
CD34	NULL
*	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
approximately	NULL
a	NULL
4-fold	NULL
induction	NULL
of	NULL
C/EBPs	NULL
steady-state	NULL
mRNA	NULL
levels	NULL
in	NULL
HL60	NULL
cells	NULL
was	NULL
detected	NULL
after	NULL
retinoic	NULL
acid	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

However	NULL
,	NULL
this	NULL
induction	NULL
was	NULL
transient	NULL
because	NULL
prolonged	NULL
treatment	NULL
with	NULL
retinoic	NULL
acid	NULL
did	NULL
not	NULL
sustain	NULL
these	NULL
high	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
+RA	NULL
2-4	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
induction	NULL
was	NULL
detected	NULL
after	NULL
1-day	NULL
treatment	NULL
of	NULL
U937	NULL
cells	NULL
with	NULL
retinoic	NULL
acid	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

TPA	NULL
treatment	NULL
did	NULL
not	NULL
have	NULL
any	NULL
effect	NULL
on	NULL
the	NULL
levels	NULL
of	NULL
C/EBPs	NULL
RNA	NULL
in	NULL
U937	NULL
but	NULL
it	NULL
decreased	NULL
the	NULL
levels	NULL
of	NULL
C/EBPs	NULL
RNA	NULL
in	NULL
HL60	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
C/EBPs	NULL
is	NULL
preferentially	NULL
expressed	NULL
during	NULL
in	NULL
vitro	NULL
differentiation	NULL
of	NULL
primary	NULL
cells	NULL
to	NULL
granulocytes	NULL
,	NULL
but	NULL
not	NULL
monocytes	NULL
,	NULL
and	NULL
is	NULL
strongly	NULL
induced	NULL
by	NULL
retinoic	NULL
acid	NULL
in	NULL
granulocytic	NULL
cells	NULL
.	NULL

The	NULL
C/EBP£	NULL
Gene	NULL
Encodes	NULL
Several	NULL
Proteins	NULL
with	NULL
Different	NULL
Transactivation	NULL
Potential	NULL
.	NULL

To	NULL
test	NULL
the	NULL
transactivation	NULL
potential	NULL
of	NULL
two	NULL
of	NULL
the	NULL
C/EBP	NULL
protein	NULL
isoforms	NULL
,	NULL
the	NULL
longest	NULL
32.2	NULL
kDa	NULL
and	NULL
the	NULL
shortest	NULL
14.3	NULL
kDa	NULL
,	NULL
we	NULL
generated	NULL
pCMV-based	NULL
expression	NULL
constructs	NULL
for	NULL
both	NULL
isoforms	NULL
.	NULL

The	NULL
integrity	NULL
of	NULL
each	NULL
expression	NULL
construct	NULL
was	NULL
verified	NULL
by	NULL
sequence	NULL
.	NULL

These	NULL
plasmids	NULL
,	NULL
a	NULL
full-length	NULL
C/EBPa	NULL
expression	NULL
construct	NULL
and	NULL
a	NULL
wild-type	NULL
and	NULL
mutant	NULL
G-CSF	NULL
receptor-luciferase	NULL
reporter	NULL
,	NULL
were	NULL
used	NULL
to	NULL
transfect	NULL
HeLa	NULL
cells	NULL
that	NULL
do	NULL
not	NULL
express	NULL
detectable	NULL
levels	NULL
of	NULL
C/EBPa	NULL
«	NULL
or	NULL
C/EBPs	NULL
.	NULL

A	NULL
cytomegalovirus-based	NULL
lacZ	NULL
expression	NULL
vector	NULL
was	NULL
also	NULL
used	NULL
to	NULL
normalize	NULL
for	NULL
transfection	NULL
effi-ciency	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
at	NULL
low	NULL
plasmid	NULL
doses	NULL
both	NULL
C/EBPa	NULL
and	NULL
C/EBP	NULL
z	NULL
``	NULL
expression	NULL
constructs	NULL
were	NULL
able	NULL
to	NULL
transactivate	NULL
the	NULL
G-CSF	NULL
receptor	NULL
promoter	NULL
3-fold	NULL
and	NULL
2-fold	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
transactivation	NULL
of	NULL
the	NULL
G-CSF	NULL
receptor	NULL
promoter	NULL
was	NULL
Fold	NULL
Transactivation	NULL
<	NULL
5	NULL
8	NULL
1	NULL
2	NULL
5	NULL
5	NULL
1	NULL
2	NULL
5	NULL
0s	NULL
0.5	NULL
0.5	NULL
goog	NULL
§	NULL
E	NULL
3	NULL
3	NULL
LLU	NULL
z	NULL
a	NULL
oa	NULL
T	NULL
o	NULL
s	NULL
o	NULL
bos	NULL
&	NULL
&	NULL
&	NULL
Ao	NULL
&	NULL
&	NULL
E	NULL
$	NULL
o	NULL
f	NULL
P|	NULL
:	NULL
3	NULL
§	NULL
§	NULL
5	NULL
5	NULL
$	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Activation	NULL
of	NULL
G-CSF	NULL
receptor	NULL
promoter-luciferase	NULL
reporter	NULL
construct	NULL
by	NULL
C/EBPa	NULL
and	NULL
C/EBPs	NULL
in	NULL
cotransfected	NULL
HeLa	NULL
cells	NULL
.	NULL

The	NULL
G-CSF	NULL
receptor-luciferase	NULL
wild	NULL
type	NULL
(	NULL
WT	NULL
)	NULL
and	NULL
mutant	NULL
(	NULL
Mut	NULL
)	NULL
have	NULL
been	NULL
described	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Increasing	NULL
amounts	NULL
of	NULL
expression	NULL
plasmids	NULL
for	NULL
C/EBPs	NULL
or	NULL
0.5	NULL
ug	NULL
of	NULL
C/EBPa	NULL
were	NULL
cotransfected	NULL
with	NULL
a	NULL
constant	NULL
amount	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
of	NULL
both	NULL
G-CSF	NULL
receptor-luciferase	NULL
reporter	NULL
plasmids	NULL
and	NULL
1	NULL
ug	NULL
of	NULL
B-galactosidase	NULL
(	NULL
pCMVB	NULL
)	NULL
reporter	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
transfected	NULL
DNA	NULL
was	NULL
adjusted	NULL
with	NULL
vector	NULL
DNA	NULL
to	NULL
10	NULL
ug	NULL
per	NULL
dish	NULL
.	NULL

The	NULL
values	NULL
are	NULL
presented	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
fold	NULL
transactivation	NULL
over	NULL
the	NULL
reporter	NULL
.	NULL

The	NULL
experiments	NULL
were	NULL
repeated	NULL
at	NULL
least	NULL
four	NULL
times	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
(	NULL
1997	NULL
)	NULL
relatively	NULL
low	NULL
,	NULL
but	NULL
this	NULL
tranasctivation	NULL
potential	NULL
was	NULL
consistently	NULL
recorded	NULL
over	NULL
several	NULL
independent	NULL
experiments	NULL
performed	NULL
in	NULL
duplicate	NULL
and	NULL
was	NULL
not	NULL
significantly	NULL
affected	NULL
by	NULL
different	NULL
plasmid	NULL
DNA	NULL
preparations	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
C/EBPs	NULL
``	NULL
failed	NULL
to	NULL
transactivate	NULL
the	NULL
reporter	NULL
gene	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
C/EBP	NULL
-binding	NULL
site	NULL
prevented	NULL
activation	NULL
by	NULL
any	NULL
of	NULL
the	NULL
C/EBP	NULL
expression	NULL
vectors	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
short	NULL
14.3-kDa	NULL
protein	NULL
isoform	NULL
lacks	NULL
the	NULL
transactivation	NULL
potential	NULL
of	NULL
the	NULL
longer	NULL
variant	NULL
.	NULL

DISCUSSION	NULL
The	NULL
C/EBP	NULL
gene	NULL
family	NULL
includes	NULL
six	NULL
members	NULL
characterized	NULL
by	NULL
highly	NULL
conserved	NULL
basic	NULL
DNA	NULL
binding	NULL
and	NULL
leucine	NULL
zipper	NULL
dimerization	NULL
domains	NULL
(	NULL
7	NULL
,	NULL
27	NULL
,	NULL
28	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
describe	NULL
several	NULL
distinct	NULL
features	NULL
of	NULL
the	NULL
C/EBPs	NULL
gene	NULL
regulation	NULL
and	NULL
mRNA	NULL
expression	NULL
patterns	NULL
that	NULL
distinguish	NULL
C/EBPs	NULL
from	NULL
the	NULL
other	NULL
C/EBP	NULL
members	NULL
.	NULL

The	NULL
C/EBPs	NULL
gene	NULL
is	NULL
transcribed	NULL
by	NULL
two	NULL
alternative	NULL
promoters	NULL
,	NULL
Pa	NULL
and	NULL
PB	NULL
,	NULL
with	NULL
a	NULL
cell-type	NULL
specificity	NULL
.	NULL

Differential	NULL
splicing	NULL
of	NULL
the	NULL
C/EBPsz	NULL
transcriptional	NULL
unit	NULL
generates	NULL
several	NULL
mRNA	NULL
isoforms	NULL
and	NULL
adds	NULL
to	NULL
the	NULL
complexity	NULL
of	NULL
the	NULL
regulation	NULL
of	NULL
this	NULL
gene	NULL
.	NULL

All	NULL
isoforms	NULL
share	NULL
the	NULL
same	NULL
last	NULL
exon	NULL
that	NULL
encodes	NULL
for	NULL
the	NULL
bZIP	NULL
carboxyl-terminal	NULL
domain	NULL
and	NULL
have	NULL
identical	NULL
3	NULL
'	NULL
untranslated	NULL
regions	NULL
.	NULL

However	NULL
,	NULL
the	NULL
N-terminal	NULL
regions	NULL
of	NULL
each	NULL
protein	NULL
are	NULL
different	NULL
.	NULL

The	NULL
structure	NULL
of	NULL
the	NULL
mouse	NULL
gene	NULL
is	NULL
similar	NULL
to	NULL
the	NULL
human	NULL
as	NULL
are	NULL
the	NULL
sequences	NULL
at	NULL
the	NULL
exon/intron	NULL
boundaries	NULL
and	NULL
the	NULL
PB	NULL
promoter	NULL
region	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
there	NULL
is	NULL
a	NULL
pronounced	NULL
homology	NULL
of	NULL
92.8	NULL
%	NULL
at	NULL
the	NULL
amino	NULL
acid	NULL
sequence	NULL
level	NULL
between	NULL
the	NULL
two	NULL
32.2-kDa	NULL
protein	NULL
isoforms	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
deduced	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
the	NULL
longest	NULL
human	NULL
C/EBPs	NULL
is	NULL
281	NULL
amino	NULL
acids	NULL
using	NULL
Pal	NULL
and	NULL
PB1	NULL
RNA	NULL
as	NULL
translational	NULL
templates	NULL
.	NULL

Alternative	NULL
translational	NULL
initiation	NULL
from	NULL
this	NULL
RNA	NULL
isoform	NULL
is	NULL
possible	NULL
because	NULL
there	NULL
are	NULL
three	NULL
in-frame	NULL
AUG	NULL
codons	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
sequence	NULL
comparisons	NULL
between	NULL
the	NULL
different	NULL
members	NULL
of	NULL
the	NULL
C/EBP	NULL
family	NULL
we	NULL
speculated	NULL
earlier	NULL
that	NULL
C/EBP	NULL
s	NULL
is	NULL
most	NULL
related	NULL
to	NULL
C/EBPa	NULL
(	NULL
9	NULL
)	NULL
.	NULL

The	NULL
homology	NULL
starts	NULL
in	NULL
the	NULL
N-terminal	NULL
region	NULL
of	NULL
C/EBPa	NULL
and	NULL
the	NULL
C/EBPs	NULL
32.2-kDa	NULL
isoform	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
first	NULL
start	NULL
codon	NULL
of	NULL
this	NULL
isoform	NULL
is	NULL
the	NULL
dominant	NULL
translational	NULL
initiation	NULL
codon	NULL
.	NULL

In	NULL
vitro	NULL
transcription/	NULL
translation	NULL
of	NULL
a	NULL
C/EBPs	NULL
cDNA	NULL
template	NULL
encoding	NULL
the	NULL
Pal	NULL
and	NULL
PBI	NULL
form	NULL
shows	NULL
that	NULL
the	NULL
first	NULL
upstream	NULL
AUG	NULL
codon	NULL
is	NULL
used	NULL
efficiently	NULL
in	NULL
vitro	NULL
,	NULL
generating	NULL
a	NULL
protein	NULL
of	NULL
32.3	NULL
kDa	NULL
.	NULL

Another	NULL
protein	NULL
is	NULL
encoded	NULL
by	NULL
transcript	NULL
P	NULL
«	NULL
2	NULL
,	NULL
which	NULL
is	NULL
129	NULL
amino	NULL
acids	NULL
long	NULL
and	NULL
has	NULL
a	NULL
calculated	NULL
molecular	NULL
mass	NULL
of	NULL
14.3	NULL
kDa	NULL
.	NULL

Finally	NULL
,	NULL
a	NULL
third	NULL
protein	NULL
that	NULL
is	NULL
252	NULL
amino	NULL
acids	NULL
long	NULL
and	NULL
has	NULL
a	NULL
calculated	NULL
molecular	NULL
mass	NULL
of	NULL
27.8	NULL
kDa	NULL
is	NULL
encoded	NULL
by	NULL
transcript	NULL
Pa3	NULL
.	NULL

In	NULL
several	NULL
tissues	NULL
and	NULL
cell	NULL
lines	NULL
tested	NULL
the	NULL
PBI1	NULL
transcript	NULL
is	NULL
by	NULL
far	NULL
the	NULL
most	NULL
abundant	NULL
(	NULL
this	NULL
study	NULL
and	NULL
refs	NULL
.	NULL

9	NULL
and	NULL
10	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
main	NULL
molecular	NULL
mechanism	NULL
for	NULL
control	NULL
of	NULL
C/EBPs	NULL
gene	NULL
expression	NULL
is	NULL
transcriptional	NULL
regulation	NULL
that	NULL
favors	NULL
initiation	NULL
from	NULL
the	NULL
PB	NULL
promoter	NULL
region	NULL
.	NULL

This	NULL
region	NULL
is	NULL
also	NULL
the	NULL
predominant	NULL
promoter	NULL
driving	NULL
expression	NULL
of	NULL
the	NULL
C/EBPs	NULL
gene	NULL
in	NULL
mice	NULL
.	NULL

Other	NULL
C/EBP	NULL
family	NULL
members	NULL
that	NULL
lack	NULL
introns	NULL
use	NULL
alternative	NULL
translation	NULL
initiation	NULL
to	NULL
generate	NULL
functionally	NULL
different	NULL
factors	NULL
.	NULL

C/EBPB	NULL
or	NULL
LAP	NULL
can	NULL
generate	NULL
two	NULL
proteins	NULL
with	NULL
distinct	NULL
functions	NULL
,	NULL
LAP	NULL
acts	NULL
as	NULL
an	NULL
activator	NULL
and	NULL
LIP	NULL
as	NULL
a	NULL
repressor	NULL
that	NULL
shares	NULL
the	NULL
same	NULL
bZIP	NULL
region	NULL
with	NULL
LAP	NULL
but	NULL
lacks	NULL
the	NULL
N-terminal	NULL
activation	NULL
domain	NULL
identified	NULL
in	NULL
LAP	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
C/EBPa	NULL
is	NULL
translated	NULL
into	NULL
multiple	NULL
proteins	NULL
with	NULL
different	NULL
transactivation	NULL
potentials	NULL
(	NULL
30	NULL
)	NULL
.	NULL

All	NULL
of	NULL
these	NULL
proteins	NULL
share	NULL
the	NULL
same	NULL
bZIP	NULL
C-terminal	NULL
domain	NULL
but	NULL
differ	NULL
in	NULL
their	NULL
N-terminal	NULL
amino	NULL
acid	NULL
sequences	NULL
.	NULL

A	NULL
ribosome-scanning	NULL
mechanism	NULL
that	NULL
selectively	NULL
uses	NULL
different	NULL
in-frame	NULL
AUGs	NULL
to	NULL
initiate	NULL
translation	NULL
from	NULL
the	NULL
same	NULL
mRNA	NULL
template	NULL
has	NULL
been	NULL
suggested	NULL
to	NULL
explain	NULL
the	NULL
production	NULL
of	NULL
multiple	NULL
C/EBPa	NULL
proteins	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
N-terminally	NULL
truncated	NULL
forms	NULL
are	NULL
produced	NULL
by	NULL
several	NULL
C/EBP	NULL
family	NULL
members	NULL
,	NULL
including	NULL
C/EBP	NULL
s	NULL
,	NULL
and	NULL
are	NULL
present	NULL
in	NULL
different	NULL
vertebrate	NULL
species	NULL
such	NULL
as	NULL
rat	NULL
,	NULL
mouse	NULL
,	NULL
human	NULL
,	NULL
chicken	NULL
,	NULL
and	NULL
Xenopus	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Isoforms	NULL
of	NULL
transcriptional	NULL
regulators	NULL
that	NULL
lack	NULL
the	NULL
transactivation	NULL
domain	NULL
are	NULL
not	NULL
uncommon	NULL
Medical	NULL
Sciences	NULL
:	NULL
Yamanaka	NULL
et	NULL
al	NULL
.	NULL

among	NULL
transcription	NULL
factors	NULL
that	NULL
act	NULL
as	NULL
dimers	NULL
.	NULL

A	NULL
heterodimer	NULL
that	NULL
contains	NULL
an	NULL
activator	NULL
and	NULL
a	NULL
repressor	NULL
will	NULL
not	NULL
be	NULL
functional	NULL
because	NULL
only	NULL
one	NULL
activation	NULL
domain	NULL
is	NULL
available	NULL
.	NULL

A	NULL
variety	NULL
of	NULL
such	NULL
examples	NULL
have	NULL
been	NULL
described	NULL
such	NULL
as	NULL
erbAa	NULL
,	NULL
mTFE3	NULL
,	NULL
Fos	NULL
B	NULL
,	NULL
and	NULL
I-POU	NULL
(	NULL
reviewed	NULL
in	NULL
ref	NULL
.	NULL

31	NULL
)	NULL
.	NULL

Repressors	NULL
can	NULL
block	NULL
transcriptional	NULL
activation	NULL
as	NULL
homodimers	NULL
by	NULL
occupying	NULL
an	NULL
important	NULL
regulatory	NULL
element	NULL
on	NULL
a	NULL
target	NULL
gene	NULL
.	NULL

Several	NULL
studies	NULL
have	NULL
demonstrated	NULL
heterodimer	NULL
formation	NULL
between	NULL
the	NULL
C/EBP	NULL
family	NULL
members	NULL
,	NULL
including	NULL
interactions	NULL
of	NULL
C/EBPs	NULL
with	NULL
C/EBPa	NULL
,	NULL
C/EBP	NULL
,	NULL
and	NULL
C/EBPS8	NULL
(	NULL
27	NULL
,	NULL
32	NULL
,	NULL
33	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
number	NULL
of	NULL
possible	NULL
combinations	NULL
of	NULL
homodimers	NULL
or	NULL
heterodimers	NULL
in	NULL
a	NULL
particular	NULL
cell	NULL
is	NULL
reduced	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
C/EBP	NULL
genes	NULL
are	NULL
expressed	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

We	NULL
reported	NULL
previously	NULL
that	NULL
expression	NULL
of	NULL
the	NULL
C/EBPs	NULL
gene	NULL
is	NULL
restricted	NULL
to	NULL
tissues	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
(	NULL
9	NULL
)	NULL
.	NULL

The	NULL
present	NULL
data	NULL
demonstrate	NULL
that	NULL
expression	NULL
of	NULL
C/EBPs	NULL
mRNA	NULL
correlates	NULL
with	NULL
granulocytic	NULL
differentiation	NULL
of	NULL
primary	NULL
CD34¢	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
also	NULL
detectable	NULL
in	NULL
CD34*CD33*	NULL
committed	NULL
precursors	NULL
and	NULL
is	NULL
highly	NULL
expressed	NULL
in	NULL
CD11b*	NULL
individual	NULL
myeloid	NULL
bone	NULL
marrow	NULL
cells	NULL
(	NULL
D.	NULL
Scadden	NULL
,	NULL
personal	NULL
communication	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
C/EBPs	NULL
mRNA	NULL
is	NULL
preferentially	NULL
expressed	NULL
in	NULL
primary	NULL
neutrophils	NULL
.	NULL

Retinoic	NULL
acid	NULL
treatment	NULL
of	NULL
HL60	NULL
promyelocytic	NULL
cells	NULL
to	NULL
promote	NULL
a	NULL
granulocytic-like	NULL
differentiation	NULL
program	NULL
greatly	NULL
induces	NULL
C/EBPs	NULL
mRNA	NULL
,	NULL
suggesting	NULL
a	NULL
role	NULL
for	NULL
C/EBP	NULL
z	NULL
in	NULL
this	NULL
pathway	NULL
.	NULL

PU.1	NULL
and	NULL
C/EBPa	NULL
are	NULL
both	NULL
expressed	NULL
early	NULL
in	NULL
myeloid	NULL
differentiation	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Both	NULL
of	NULL
these	NULL
factors	NULL
together	NULL
with	NULL
a	NULL
nonidentified	NULL
``	NULL
band-X	NULL
``	NULL
factor	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
G-CSF	NULL
receptor	NULL
promoter	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
transactivation	NULL
potential	NULL
of	NULL
the	NULL
long	NULL
form	NULL
of	NULL
C/EBPs	NULL
on	NULL
G-CSF	NULL
promoter	NULL
reporter	NULL
construct	NULL
,	NULL
although	NULL
low	NULL
under	NULL
our	NULL
experimental	NULL
conditions	NULL
,	NULL
indicates	NULL
that	NULL
C/EBP	NULL
s	NULL
may	NULL
also	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
this	NULL
gene	NULL
.	NULL

The	NULL
myeloperoxidase	NULL
gene	NULL
initiates	NULL
transcription	NULL
from	NULL
two	NULL
promoters	NULL
separated	NULL
by	NULL
approximately	NULL
400	NULL
bp	NULL
(	NULL
35	NULL
)	NULL
,	NULL
and	NULL
is	NULL
a	NULL
target	NULL
of	NULL
C/EBP	NULL
proteins	NULL
and	NULL
PU.1	NULL
during	NULL
granulocytic	NULL
differentiation	NULL
(	NULL
36	NULL
)	NULL
.	NULL

C/EBPa	NULL
,	NULL
C/EBP	NULL
B	NULL
,	NULL
and	NULL
C/EBP8	NULL
are	NULL
expressed	NULL
in	NULL
an	NULL
overlapping	NULL
manner	NULL
during	NULL
in	NULL
vitro	NULL
granulocytic	NULL
differentiation	NULL
of	NULL
A4	NULL
multi-potential	NULL
progenitor	NULL
cells	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
its	NULL
expression	NULL
pattern	NULL
C/EBPs	NULL
may	NULL
also	NULL
interact	NULL
with	NULL
the	NULL
myeloperoxidase	NULL
promoter	NULL
regions	NULL
.	NULL

The	NULL
functional	NULL
versatility	NULL
of	NULL
the	NULL
C/EBPs	NULL
gene	NULL
is	NULL
mirrored	NULL
by	NULL
the	NULL
number	NULL
of	NULL
C/EBPs	NULL
RNA	NULL
isoforms	NULL
that	NULL
are	NULL
produced	NULL
in	NULL
a	NULL
cell-and	NULL
tissue-specific	NULL
manner	NULL
.	NULL

Alternative	NULL
use	NULL
of	NULL
promoters	NULL
and	NULL
differential	NULL
splicing	NULL
of	NULL
the	NULL
primary	NULL
transcriptional	NULL
unit	NULL
,	NULL
unique	NULL
among	NULL
the	NULL
C/EBP	NULL
family	NULL
members	NULL
,	NULL
results	NULL
in	NULL
ORFs	NULL
that	NULL
change	NULL
the	NULL
characteristics	NULL
of	NULL
the	NULL
protein	NULL
and	NULL
may	NULL
modulate	NULL
its	NULL
physiological	NULL
role	NULL
.	NULL

Such	NULL
molecular	NULL
mechanisms	NULL
are	NULL
shared	NULL
by	NULL
other	NULL
transcriptional	NULL
regulators	NULL
with	NULL
modular	NULL
structures	NULL
such	NULL
as	NULL
CREM	NULL
(	NULL
37	NULL
)	NULL
,	NULL
CREB	NULL
(	NULL
38	NULL
)	NULL
,	NULL
and	NULL
HLF	NULL
(	NULL
39	NULL
)	NULL
.	NULL

The	NULL
modulatory	NULL
structure	NULL
of	NULL
the	NULL
C/EBP	NULL
s	NULL
gene	NULL
may	NULL
also	NULL
be	NULL
an	NULL
indication	NULL
of	NULL
its	NULL
evolutionary	NULL
origin	NULL
,	NULL
perhaps	NULL
reflecting	NULL
an	NULL
assembly	NULL
of	NULL
subunits	NULL
with	NULL
distinct	NULL
function	NULL
.	NULL

The	NULL
use	NULL
of	NULL
alternative	NULL
promoter	NULL
regions	NULL
that	NULL
are	NULL
somewhat	NULL
related	NULL
may	NULL
indicate	NULL
that	NULL
a	NULL
duplication	NULL
of	NULL
the	NULL
first	NULL
modular	NULL
unit	NULL
has	NULL
recently	NULL
occurred	NULL
.	NULL

It	NULL
is	NULL
a	NULL
tantalizing	NULL
possibility	NULL
that	NULL
C/EBPs	NULL
may	NULL
be	NULL
the	NULL
evolutionary	NULL
remnant	NULL
of	NULL
a	NULL
primordial	NULL
C/EBP	NULL
gene	NULL
with	NULL
a	NULL
modular	NULL
structure	NULL
.	NULL

The	NULL
significance	NULL
of	NULL
the	NULL
C/EBPsz	NULL
gene	NULL
as	NULL
an	NULL
important	NULL
regulator	NULL
of	NULL
the	NULL
differentiation	NULL
process	NULL
in	NULL
hematopoiesis	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
demonstrated	NULL
in	NULL
vivo	NULL
.	NULL

Our	NULL
data	NULL
suggest	NULL
that	NULL
this	NULL
protein	NULL
may	NULL
be	NULL
important	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
certain	NULL
genes	NULL
such	NULL
as	NULL
the	NULL
G-CSF	NULL
receptor	NULL
and	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
granulocytic	NULL
differentiation	NULL
.	NULL

The	NULL
ultimate	NULL
demonstration	NULL
of	NULL
the	NULL
role	NULL
of	NULL
C/EBP	NULL
s	NULL
in	NULL
the	NULL
hematopoietic	NULL
system	NULL
may	NULL
have	NULL
to	NULL
wait	NULL
for	NULL
a	NULL
functional	NULL
analysis	NULL
of	NULL
this	NULL
gene	NULL
using	NULL
the	NULL
powerful	NULL
tools	NULL
of	NULL
mouse	NULL
genetics	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
Drs	NULL
.	NULL

C.	NULL
Barlow	NULL
,	NULL
D.	NULL
Nelson	NULL
,	NULL
and	NULL
A.	NULL
Wynshaw-Boris	NULL
for	NULL
critical	NULL
review	NULL
of	NULL
the	NULL
manuscript	NULL
and	NULL
to	NULL
Dr.	NULL
R.	NULL
Michael	NULL
Blaese	NULL
for	NULL
generous	NULL
support	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Dr.	NULL
Jeffrey	NULL
Marx	NULL
for	NULL
help	NULL
with	NULL
CD34*	NULL
cell	NULL
isolation	NULL
.	NULL

D.G.T	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
CA41456	NULL
and	NULL
DK48660	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
(	NULL
1997	NULL
)	NULL
6467	NULL
Ness	NULL
,	NULL
S.	NULL
A	NULL
.	NULL

&	NULL
Engel	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

4	NULL
,	NULL
718-724	NULL
.	NULL

Shivdasani	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

&	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1996	NULL
)	NULL
Blood	NULL
87	NULL
,	NULL
4025-4039	NULL
.	NULL

Tenen	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Hromas	NULL
,	NULL
R.	NULL
,	NULL
Licht	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Zhang	NULL
,	NULL
D.-E.	NULL
(	NULL
1997	NULL
)	NULL
Blood	NULL
,	NULL
in	NULL
press	NULL
.	NULL

Scott	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Civin	NULL
,	NULL
C.	NULL
I.	NULL
,	NULL
Rorth	NULL
,	NULL
P.	NULL
&	NULL
Friedman	NULL
,	NULL
A.	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
Blood	NULL
80	NULL
,	NULL
1725-1735	NULL
.	NULL

Wedel	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Ziegler-Heitbrock	NULL
,	NULL
H.	NULL
W.	NULL
L..	NULL
(	NULL
1995	NULL
)	NULL
Immunobiology	NULL
193	NULL
,	NULL
171-185	NULL
.	NULL

Johnson	NULL
,	NULL
P.	NULL
F.	NULL
&	NULL
McKnight	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1989	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

58	NULL
,	NULL
799-839	NULL
.	NULL

Xanthopoulos	NULL
,	NULL
K.	NULL
G.	NULL
&	NULL
Mirkovitch	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

216	NULL
,	NULL
353-360	NULL
.	NULL

Koldin	NULL
,	NULL
B.	NULL
,	NULL
Suckow	NULL
,	NULL
M.	NULL
,	NULL
Seydel	NULL
,	NULL
A.	NULL
,	NULL
Wilken-Bergmann	NULL
,	NULL
B.	NULL
V.	NULL
&	NULL
Muller-Hill	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

23	NULL
,	NULL
4162-4169	NULL
.	NULL

Antonson	NULL
,	NULL
P.	NULL
,	NULL
Stellan	NULL
,	NULL
B.	NULL
,	NULL
Yamanaka	NULL
,	NULL
R.	NULL
&	NULL
Xanthopoulos	NULL
,	NULL
K.	NULL
G.	NULL
(	NULL
1996	NULL
)	NULL
Genomics	NULL
35	NULL
,	NULL
30-38	NULL
.	NULL

Chumakov	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Grillier	NULL
,	NULL
I.	NULL
,	NULL
Chumakova	NULL
,	NULL
E.	NULL
,	NULL
Chih	NULL
,	NULL
D.	NULL
,	NULL
Slater	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Koeffler	NULL
,	NULL
H.	NULL
P.	NULL
(	NULL
1997	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17	NULL
,	NULL
1375-1386.	NULL
Cooper	NULL
,	NULL
C.	NULL
,	NULL
Henderson	NULL
,	NULL
A.	NULL
,	NULL
Artandi	NULL
,	NULL
S.	NULL
,	NULL
Avitahl	NULL
,	NULL
N.	NULL
&	NULL
Calame	NULL
,	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

23	NULL
,	NULL
4371-4377	NULL
.	NULL

Barone	NULL
,	NULL
M.	NULL
V.	NULL
,	NULL
Crozat	NULL
,	NULL
A.	NULL
,	NULL
Tabace	NULL
,	NULL
A.	NULL
,	NULL
Philipson	NULL
,	NULL
L.	NULL
&	NULL
Ron	NULL
,	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

8	NULL
,	NULL
453-464	NULL
.	NULL

Vinson	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
Hai	NULL
,	NULL
T.	NULL
&	NULL
Boyd	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
1047-1058	NULL
.	NULL

Hsu	NULL
,	NULL
W.	NULL
,	NULL
Kerpolla	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
Chen	NULL
,	NULL
P.	NULL
L.	NULL
,	NULL
Curran	NULL
,	NULL
T.	NULL
&	NULL
Chen-Kiang	NULL
,	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
268-276	NULL
.	NULL

LeClair	NULL
,	NULL
K.	NULL
P.	NULL
,	NULL
Blanar	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

&	NULL
Sharp	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
,	NULL
8145-8149	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
Cogswell	NULL
,	NULL
P.	NULL
C.	NULL
&	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
,	NULL
3964-3974	NULL
.	NULL

Jenkins	NULL
,	NULL
N.	NULL
C.	NULL
,	NULL
Gilbert	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Cho	NULL
,	NULL
B.	NULL
C.	NULL
,	NULL
Strobel	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Williams	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Copeland	NULL
,	NULL
N.	NULL
G.	NULL
&	NULL
Johnson	NULL
,	NULL
P.	NULL
F.	NULL
(	NULL
1995	NULL
)	NULL
Genomics	NULL
28	NULL
,	NULL
333-336	NULL
.	NULL

Lui	NULL
,	NULL
F.	NULL
,	NULL
Wu	NULL
,	NULL
H.	NULL
Y.	NULL
,	NULL
Wesselsschmidt	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Kornaga	NULL
,	NULL
T.	NULL
&	NULL
Link	NULL
,	NULL
D.	NULL
C.	NULL
(	NULL
1996	NULL
)	NULL
Immunity	NULL
5	NULL
,	NULL
491-501	NULL
.	NULL

Maniatis	NULL
,	NULL
T.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
&	NULL
Sambrook	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
(	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Lab	NULL
.	NULL

Press	NULL
,	NULL
Plainview	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
2nd	NULL
Ed	NULL
.	NULL

Torezynski	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Fuke	NULL
,	NULL
M.	NULL
&	NULL
Bollon	NULL
,	NULL
A.	NULL
P.	NULL
(	NULL
1985	NULL
)	NULL
DNA	NULL
4	NULL
,	NULL
283-291	NULL
.	NULL

Barbu	NULL
,	NULL
V.	NULL
&	NULL
Dautry	NULL
,	NULL
F.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
7115	NULL
.	NULL

Chen	NULL
,	NULL
H.-M.	NULL
,	NULL
Zhang	NULL
,	NULL
P.	NULL
,	NULL
Voso	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
Hohaus	NULL
,	NULL
S.	NULL
,	NULL
Gonzalez	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Glass	NULL
,	NULL
C.	NULL
K.	NULL
,	NULL
Zhang	NULL
,	NULL
D.-E.	NULL
&	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
Blood	NULL
85	NULL
,	NULL
2918-2928	NULL
.	NULL

Nordeen	NULL
,	NULL
S.	NULL
K.	NULL
(	NULL
1988	NULL
)	NULL
BioTechniques	NULL
6	NULL
,	NULL
454-457	NULL
.	NULL

Smith	NULL
,	NULL
L.	NULL
T.	NULL
,	NULL
Hohaus	NULL
,	NULL
S.	NULL
,	NULL
Gonzalez	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Dziennis	NULL
,	NULL
S.	NULL
E.	NULL
&	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1996	NULL
)	NULL
Blood	NULL
88	NULL
,	NULL
1234-1247	NULL
.	NULL

Antonson	NULL
,	NULL
P.	NULL
,	NULL
Pray	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Jacobsson	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Xanthopoulos	NULL
,	NULL
K.	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

232	NULL
,	NULL
397-403	NULL
.	NULL

Kozak	NULL
,	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

115	NULL
,	NULL
887-903	NULL
.	NULL

Cao	NULL
,	NULL
Z.	NULL
,	NULL
Umek	NULL
,	NULL
R.	NULL
M.	NULL
&	NULL
McKnight	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

5	NULL
,	NULL
1538-1552	NULL
.	NULL

McKnight	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1992	NULL
)	NULL
in	NULL
Transcriptional	NULL
Regulation	NULL
,	NULL
eds	NULL
.	NULL

McKnight	NULL
,	NULL
S.	NULL
L.	NULL
&	NULL
Yamamoto	NULL
,	NULL
K.	NULL
(	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Lab	NULL
.	NULL

Press	NULL
,	NULL
Plainview	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
pp	NULL
.	NULL

771-795	NULL
.	NULL

Descombes	NULL
,	NULL
P.	NULL
&	NULL
Schibler	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Cell	NULL
67	NULL
,	NULL
569-579	NULL
.	NULL

Ossipow	NULL
,	NULL
V.	NULL
,	NULL
Descombes	NULL
,	NULL
P.	NULL
&	NULL
Schibler	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Nail	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
,	NULL
8219-8223	NULL
.	NULL

Foulkes	NULL
,	NULL
N.	NULL
S.	NULL
&	NULL
Sassone-Corsi	NULL
,	NULL
P.	NULL
(	NULL
1992	NULL
)	NULL
Cell	NULL
68	NULL
,	NULL
411-414	NULL
.	NULL

Poli	NULL
,	NULL
V.	NULL
,	NULL
Mancini	NULL
,	NULL
F.	NULL
P.	NULL
&	NULL
Cortese	NULL
,	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
63	NULL
,	NULL
643-653	NULL
.	NULL

Williams	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Cantwell	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

&	NULL
Johnson	NULL
,	NULL
P.	NULL
F.	NULL
(	NULL
1991	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

5	NULL
,	NULL
1553-1567	NULL
.	NULL

Voso	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
Burn	NULL
,	NULL
T.	NULL
C.	NULL
,	NULL
Wulf	NULL
,	NULL
G.	NULL
,	NULL
Lim	NULL
,	NULL
B.	NULL
,	NULL
Leone	NULL
,	NULL
G.	NULL
&	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
17	NULL
,	NULL
7932-7936	NULL
.	NULL

Friedman	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Krieder	NULL
,	NULL
B.	NULL
L.	NULL
,	NULL
Venturelli	NULL
,	NULL
D.	NULL
&	NULL
Rovera	NULL
,	NULL
G.	NULL
(	NULL
1991	NULL
)	NULL
Blood	NULL
78	NULL
,	NULL
2426-2432	NULL
.	NULL

Ford	NULL
,	NULL
A.	NULL
,	NULL
Bennett	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Healy	NULL
,	NULL
L.	NULL
Y.	NULL
,	NULL
Towatari	NULL
,	NULL
M.	NULL
,	NULL
Greaves	NULL
,	NULL
M.	NULL
F.	NULL
&	NULL
Enver	NULL
,	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
Proc	NULL
.	NULL

Nail	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
,	NULL
10838-10843	NULL
.	NULL

Laoide	NULL
,	NULL
B.	NULL
M.	NULL
,	NULL
Foulkes	NULL
,	NULL
N.	NULL
S.	NULL
,	NULL
Schlotter	NULL
,	NULL
F.	NULL
&	NULL
Sassone-Corsi	NULL
,	NULL
P.	NULL
(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
1179-1191	NULL
.	NULL

Ruppert	NULL
,	NULL
S.	NULL
,	NULL
Cole	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Boshart	NULL
,	NULL
M.	NULL
,	NULL
Schmid	NULL
,	NULL
E.	NULL
&	NULL
Schutz	NULL
,	NULL
G.	NULL
(	NULL
1992	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

4	NULL
,	NULL
1503-1512	NULL
.	NULL

Falvey	NULL
,	NULL
E.	NULL
,	NULL
Fleury-Olella	NULL
,	NULL
F.	NULL
&	NULL
Schibler	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

14	NULL
,	NULL
4307-4317	NULL
.	NULL

